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severe maternal morbidity (SMM) has been 
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quality indicator of obstetric care and maternal 
welfare, particularly in developed countries 
where maternal death rates are relatively low. 
Further, there is evidence that commonly 
occurring life-threatening complications 
occurring during or shortly after pregnancy, 
such as major obstetric haemorrhage (MOH), 
are underexposed as they less frequently lead 
to death in high-resourced countries. In this 
context, the NPEC, in collaboration with the 
NPEC Maternal Morbidity Advisory Group, has 
collected and analysed anonymised data on 
SMM from Irish units since 2011. I extend my 
thanks to the members of the group, listed in 
Appendix A, for their guidance and support.
The absence of international consensus on 
definitions of SMM is problematic and impedes 
comparative analysis and uniform case 
identification between similarly resourced 
countries. Various definitions include disease 
specific criteria, intervention based criteria 
and organ dysfunction criteria. To allow for 
international comparison, the NPEC adapted 
the validated methodology of the Scottish 
Confidential Audit Severe Maternal Morbidity 
(SCASMM) to evaluate SMM in Ireland. This 
methodology utilises organ dysfunction 
criteria described by Mantel et al.1 with 
modifications used by SCASMM to include 
intervention based criteria. The NPEC would like 
to acknowledge with thanks the Reproductive 
Health Programme of the National Health 
Service (NHS) Quality Improvement Scotland 
for permission to modify and use their Severe 
Maternal Morbidity data collection tools.
For the first three years of the NPEC national 
audit of SMM, a detailed audit of major obstetric 
haemorrhage was undertaken simultaneously. 
This has provided valuable data on the 
management of the most commonly occurring 
SMM, as detailed in the 2013 SMM Report.2
In January 2014, the NPEC in collaboration with 
the NPEC SMM group initiated a confidential 
audit on Critical Care in Obstetrics in Ireland. 
The purpose of this audit was to address the 
dearth of national data on the prevalence rates 
for women who require Level 2 and Level 3 
Care and the location where higher levels of 
care are provided. This audit compliments the 
Intensive Care National Audit and Research 
Centre (ICNARC) audit3 and it gives me great 
pleasure to present the findings in Section Two 
of this report. 
A number of recommendations for learning 
and improvements have been made based on 
the findings in this report. In order to ensure 
that learning is achieved from this and other 
NPEC audit reports, the NPEC aligned with the 
National Office of Clinical Audit (NOCA) in 2014. 
NOCA supports institutions and individuals to 
review and action audit findings arising from 
national clinical audit: effectively it aims to 
close the audit loop, an initiative which the 
NPEC regards as imperative to its mission. The 
NOCA Governance Board endorsement of this 
report is in Appendix B.  
Support from all Irish maternity units is 
instrumental to the success of this national 
audit. On behalf of the NPEC, I extend my 
sincere thanks and appreciation to the many 
midwives, obstetricians and administration 
staff who have voluntarily contributed data. 
In particular, I gratefully acknowledge the 
1 Mantel G et al. Severe acute maternal morbidity: a pilot study of a definition for a near-miss. BJOG 1998; 105: 985-90.
2 Corcoran P, Manning E, Meaney S, Greene RA, on behalf of the Maternal Morbidity Advisory Group. Severe Maternal Morbidity in Ireland 
Annual Report 2012 and 2013. Cork: National Perinatal Epidemiology Centre, 2015
3 Intensive Care National Audit and Research Centre (ICNARC) https://www.icnarc.org/
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Executive summary
This is the third report from the national audit 
of severe maternal morbidity (SMM) in Ireland. 
It reports on 365 cases of SMM that occurred 
in 18 of the 19 Irish maternity units in 2014. 
It also reports on findings from the first 
national audit of critical care in obstetrics in 
Ireland. Fifteen of the 19 Irish maternity units 
contributed to the critical care in obstetric 
audit in 2014, including two large tertiary 
referral maternity units and thirteen smaller 
maternity units. 
In 2014, the eighteen participating maternity 
units reported that 365 women experienced 
SMM, as defined in this audit, constituting 
a rate of 5.93 per 1,000 maternities. From 
2011 to 2014, the SMM rate varied from 3.83 
to 5.93 per 1,000 maternities or from one in 
260 maternities to one in 170 maternities. 
Respectively, the SMM rate was 16%, 24% and 
55% higher in 2012, 2013 and 2014 than in the 
base year 2011. Despite this, the incidence 
of SMM in Ireland compares favourably with 
the rate reported from the methodologically 
comparable national audit in Scottish 
maternity units (SCASMM) over similar years. 
The most recently reported Scottish SMM rate 
is 7.3 per 1,000 maternities for 2012.
Almost three quarters of the women (71.8%) 
who experienced SMM in 2014 were diagnosed 
with one SMM; 23% were diagnosed with 
two severe morbidities; 4% with three; and 
1% of the women were diagnosed with four 
morbidities.
In the first three years of the NPEC SMM 
audit, major obstetric haemorrhage (MOH) 
was the most frequently reported SMM event. 
This changed in 2014, as admission to an 
intensive or coronary care unit (ICU/CCU) was 
marginally more often reported (47.1% for ICU 
admission and 46.6% for MOH).
Half of the women admitted into an ICU/CCU in 
2014 had not experienced a severe morbidity 
as defined by this audit. This phenomenon 
has increased over the four years of the SMM 
audit, from 25% in 2011, to 35% in 2012, 41% in 
2013 and 48% in 2014. Discussions with unit 
personnel suggest such ICU/CCU admissions 
reflect resource issues in maternity units in 
cases where women require a higher level of 
monitoring. Findings from the audit of Critical 
Care in Obstetrics in Ireland in 2014 support 
this suggestion.
The incidence of MOH was 2.76 per 1,000 
maternities in 2014. The equivalent incidence 
of MOH for the most recent year with data 
in Scotland (2012) was 5.8 per 1,000 
maternities, more than twice the Irish rate.
The next most common reportable SMM 
events were renal or liver dysfunction 
(11%), peripartum hysterectomy (5.8%), 
septicaemic shock (5.8%) and pulmonary 
embolism (4.7 %). 
There were 21 reported cases of peripartum 
hysterectomy (PH). The national PH rate 
in Ireland is consistently around 0.34 per 
1,000 maternities or approximately one in 
every 3,000 maternities. This rate is similar 
to national rates reported in the UK and the 
Netherlands of 0.41 and 0.33 per 1,000 births 
respectively.
There were 21 cases of septic shock reported 
for 2014, a small increase on the sixteen 
cases reported for 2013. These numbers are 
in contrast with the four reported cases in 
each of the first two years of the audit. This 
may be a true increase in incidence or may be 
associated with an increased awareness and 
recognition of sepsis.
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Recent reports on maternal mortality in 
Ireland and the UK have identified thrombosis/
thromboembolism as a leading cause of 
maternal deaths due to direct obstetric 
causes. At 0.28 per 1,000 maternities or one 
in 3,600 women, the incidence of pulmonary 
embolism (PE) in 2014 was similar to the 
reported rate in 2011-2013.
Variation in rates of SMM and MOH were 
identified between units. However, differences 
between units must be interpreted with 
caution, as they are likely related to 
differences in the risk profile of the pregnant 
women presenting to the units rather than the 
care given. Variances in rates of MOH between 
units may also reflect variances in practices 
of estimating blood loss.  
For the first time in 2014, nine of the 18 units 
that participated in the SMM audit also provided 
data on all deliveries classified according to 
the Robson Ten Groups Classification System. 
This group constituted three quarters (73.9%) 
of the 61,593 deliveries in the 18 units that 
participated in the SMM audit. There was 
evidence of increased risk of MOH in Group 
8 (women with multiple pregnancies) and 
increased risk of other SMM in Group 10 
(women with premature deliveries).
The perinatal mortality rate (PMR) among 
infants born to women who experienced SMM 
was 57.6 per 1,000 births, i.e. one in 17 of the 
infants died. This is eight times the perinatal 
mortality rate observed for all births in Ireland. 
However, this rate is similar to findings in 2013 
and is in line with the perinatal mortality rate 
amongst infants born to women with SMM in 
Scotland in recent years, which ranged from 
17 to 64 per 1,000 maternities.
Similar to findings in 2013, multiple pregnancy 
was associated with a more than fourfold 
increased risk of SMM. The SMM rate was 
5.2 per 1,000 maternities associated with 
singleton pregnancy in 2014 and was 20.0 
per 1,000 maternities for multiple pregnancy.
In 2014, the SMM audit recorded the level of 
maternal care provided. Virtually all of the 
women who experience SMM in 2014 required 
an increased level of support/critical care. 
Over one third required Level 1 Care, half 
required Level 2 Care and one in ten required 
Level 3 Care.
The first audit on critical care in obstetrics in 
Ireland identified that the incidence of women 
requiring Level 2 Care was 5.19 per 1,000 
maternities or one in 193 maternities. For 
women requiring Level 3 Care, the incidence 
was 0.57 per 1,000 maternities or one in 
1,768 maternities.
For the vast majority of women requiring 
Level 2 Care (92%) and women requiring 
Level 3 Care (83%), the duration of care did 
not exceed three days.
While the location of care for women requiring 
Level 3 Care was primarily in an ICU/CCU 
facility, the location of care for women 
requiring Level 2 Care varied depending on 
the size of the maternity unit. The smaller the 
maternity unit, the greater the utilisation of 
ICU/CCU facilities. This may reflect differences 
in resources between maternity units with 
regard to the availability of obstetric Level 
2 Care and possibly an over utilisation of 
available ICU/CCU facilities.
Basic cardiovascular support (BCVS) was 
the most common (66.7%) organ support 
provided for women requiring Level 2 Care 
while advanced respiratory support was the 
most common support (62.5%) provided for 
women requiring Level 3 Care. 
In women requiring Level 2 Care, hypertensive 
disorders were present in over half (52.3%) 
of the women and nearly a third (29.1%) had 
an obstetric haemorrhage. In those requiring 
Level 3 Care, one in five women (20.8%) 
had a hypertensive disorder and nearly one 
third (29.2%) had an obstetric haemorrhage. 
A further one third (37.5%) of the women 
requiring Level 3 Care had a medical disorder 
which was not a direct complication of the 
pregnancy state but was classified as an 
indirect morbidity.
10  Severe Maternal Morbidity in Ireland Annual Repor t 2014
Over one third of women requiring Level 
2 Care did not meet the criteria of SMM as 
defined in the NPEC SMM audit and less than 
one in five met the criteria for Near Miss (NM) 
as defined by the World Health Organisation 
(WHO). Considering the NPEC SMM and WHO 
NM definitions utilise organ dysfunction 
criteria it is evident that a significant minority 
of women requiring Level 2 Care do not 
experience organ dysfunction, as their clinical 
needs are identified and treated before organ 
dysfunction occurs. 
In summary, the findings of this national SMM 
audit highlight the clear need for on-going 
prospective audit in order to identify adverse 
maternal outcomes. Although SMM may reflect 
the complexity of the pregnant population, it 
also acts as a surrogate measure of quality of 
care in the maternity services.
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Recommendations
• All	 maternity	 units	 should	 continue
to collect and submit data on severe
maternal morbidity to inform the
maternity services through the NPEC
national audit on severe maternal
morbidity. A multidisciplinary approach, 
involving consultant obstetricians,
consultant anaesthetists, senior
midwives and senior trainees is
recommended to ensure complete
case ascertainment. Regular
multidisciplinary meetings may assist
this approach.
• Robust	 clinical	 audit	 of	 perinatal
outcomes in all maternity units in
Ireland is vital for patient care. Such
audit requires the protected time
of clinical staff. Funding should
be provided by the Health Service
Executive (HSE) to ensure that staffing
levels allow protected time for clinical
audit.
• Formal	 counselling	 support	 should	 be
made available for all women and their
partners following a severe maternal
morbidity: this is already currently
available in some units but not all.
• The	NPEC	endorses	the	multidisciplinary
training in the management of
postpartum haemorrhage advocated
by the National Clinical Programme
for Obstetrics and Gynaecology. We
recommend the development and
national implementation of a specific
proforma to improve management and
documentation during a major obstetric 
haemorrhage event, whether in the
antenatal or postnatal period.
• A	 quantitative	 approach	 involving
volume and weight assessment
to estimate blood loss should be
considered for use in all maternity
units. Development of a national tool-kit 
would assist standardisation of such an 
approach.
• Ongoing	national	audit	on	the	provision
of critical care in obstetrics is warranted 
in order to identify the critical care needs 
for pregnant and recently pregnant
women at national level and to inform
the planning of maternity services.
• The	 location	where	critical	 care	 for	 the
pregnant or recently pregnant woman
is provided varies across maternity
units according to available resources:
in small units, critical care is often
provided in the ICU/CCU. Therefore, it
recommended that in such units, the
appropriate resources and training
for the care of the critically ill woman
in obstetrics are in place within the
ICU/CCU. For maternity units with
greater than 2,500 births per annum,
consideration should be given to
resourcing the unit with the capacity to
provide Level 2 Care.
Based on the findings of this report, the NPEC makes the following recommendations:
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Note: On site ICU: Intensive Care Unit on the hospital campus 
General High Dependency Unit: on site hospital campus caring for both obstetric and non-obstetric patients         
Obstetric High Dependency Unit: A HDU in the maternity unit that has the facilities to provide ongoing Level 2 Care for the critically ill woman in obstetrics. 
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Data recording
There were 20 maternity units in Ireland 
in 2012 and 2013 and 19 maternity units 
from February 2014. Nineteen of the units 
contributed data to this audit for 2012; 20 
units for 2013; and 18 of 19 units contributed 
in 2014. It is expected that data will be provided 
by all maternity centres in future audits. The 
individual contributors and co-ordinators for 
the audit within each participating maternity 
unit are listed in Appendix C. These are 
designated midwives, obstetric consultants 
or specialist registrars who complete the 
NPEC Severe Maternal Morbidity Notification 
Form (Appendix E). This is a validated data 
collection tool originally designed for the 
Scottish Confidential Audit of Severe Maternal 
Morbidity (SCASMM). The form was adapted 
for the Irish setting and contains information 
on maternal and delivery characteristics.
In this audit, a case of severe maternal 
morbidity (SMM) was defined as a 
pregnant or recently-pregnant woman who 
experienced any of the following seventeen 
maternal morbidities in 2012, 2013 and 
2014: major obstetric haemorrhage (MOH), 
uterine rupture, peripartum hysterectomy, 
eclampsia, renal or liver dysfunction, 
pulmonary oedema, acute respiratory 
dysfunction, pulmonary embolism, cardiac 
arrest, coma, cerebrovascular event, status 
epilepticus, septicaemic shock, anaesthetic 
complications, admission to an intensive care 
or coronary care unit, interventional radiology 
and other severe morbidity. Definitions for 
these morbidities are provided at the end of 
the notification form (Appendix E).
The other severe morbidity category was 
included to explore whether further specific 
morbidities warrant inclusion in the audit. 
Findings are not provided in this report for 
cases in this category unless one of the other 
specified morbidities was also experienced.
In 2012, 2013 and 2014, uterine rupture was a 
specified morbidity for the audit whereas this 
was not the case in 2011, the first year of the 
audit. This change has led to a small increase 
in reportable cases of SMM. However, most 
cases of uterine rupture meet the criteria 
for major obstetric haemorrhage and were 
therefore reported in all four years of the 
audit.
Denominator data on the number of maternities 
were provided by the Healthcare Pricing Office 
(HPO).4 The denominator underestimates the 
number of women at risk of SMM as it does 
not include miscarriage, ectopic pregnancy 
and molar pregnancy, which may be reported 
as cases of SMM and thereby included in 
the numerator. However, complete data on 
maternities resulting in miscarriage, ectopic 
pregnancy and molar pregnancy are not 
available and therefore, to ensure uniformity, 
the denominator was restricted to live 
births and stillbirths of babies weighing at 
least 500g. The approach of not including 
miscarriage, ectopic pregnancy and molar 
pregnancy in the denominator is also the 
approach taken by the Scottish Confidential 
Audit of Severe Maternal Morbidity.
Methods
4 Healthcare Pricing Office. (2015) Perinatal Statistics Report 2014. Dublin: Health Service Executive.
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For the first time in 2014, nine of the 18 units 
that participated in the SMM audit also provided 
data on deliveries classified according to the 
Robson Ten Group Classification System5 
(Appendix F). The incidence of MOH and other 
SMM were classified according to Robson 
Groups for these nine units. The deliveries in 
these units constituted three quarters of the 
deliveries in the 18 units that participated in 
the SMM audit.
In January 2014 an audit on Critical Care 
in Obstetrics in Ireland was initiated by the 
NPEC. Levels of care were defined using 
National Guidelines for the Critically Ill Woman 
in Obstetrics (Appendix G).6 Fifteen of the 19 
Irish maternity units contributed to this audit 
in 2014, two large tertiary referral maternity 
units and thirteen smaller maternity units. 
In the case of a woman requiring Level 2 or 
Level 3 Care, participating units were asked 
to complete an additional proforma (Appendix 
H). The main clinical diagnosis, organ support 
required and specialist review during the 
critical care event were identified. Additional 
data on maternal demographics and neonatal 
outcomes were reported on the NPEC SMM 
notification form. 
Maternal morbidity was classified as direct, 
indirect or coincidental based on the main 
clinical diagnosis during the critical care 
event, using the WHO classification for 
maternal mortality (Appendix I).7 Morbidity 
was further categorised using three different 
models for defining maternal morbidity: (a) 
the WHO disease specific criteria Severe 
Maternal Complications (SMC) (Appendix 
J): (b) the WHO organ-dysfunction criteria 
defined as Near Miss (NM)8 (Appendix K) and 
(c) the NPEC SMM methodology which utilises 
organ dysfunction and management based
criteria.
Data analysis
In keeping with the international published 
literature in this area, the incidence rate of 
SMM and of specific morbidities are calculated 
per 1,000 maternities resulting in the live 
birth or stillbirth of a baby weighing at least 
500g. For incidence rates, 95% confidence 
intervals were calculated using the Normal 
approximation of a binomial proportion 
confidence interval.
Funnel plots are used to illustrate both 
the variation in incidence rates across 
participating maternity units and the 
deviation of the rate for each individual unit 
from the national rate. 
The national rate is plotted as a straight line. A 
95% confidence interval for the national rate 
is plotted using a dashed line. The width of the 
confidence interval is adjusted to allow for 
meaningful comparison between unit-specific 
rates and the national rate. The confidence 
interval is wider for smaller units reflecting 
the lack of precision in rates calculated based 
on small numbers. The confidence interval 
narrows for larger maternity units, giving 
the diagram a ‘funnel’ shape. Maternity unit 
rates outside the 95% confidence interval are 
statistically significantly different from the 
national rate. In general, one in 20 units would 
be expected to lie outside the 95% confidence 
interval by chance alone.
Some of the variation in rates across maternity 
units will be due to differences in the profile 
of the women attending the maternity units. 
Data are not available to allow for adjustment 
of the profile of women attending the 
country’s maternity units. For this reason, 
we recommend conservative interpretation 
of differences between the rates of units and 
their deviation from the national rate.
5 Robson MS (2001). Classification of caesarean sections. Fetal and Maternal Medicine Review, 12, pp 23-39 doi:10.1017/
S0965539501000122.
6 Clinical Practice Guideline No 30 (2014). Guideline for the Critically ill Woman in Obstetrics : Institute of Obstetricians and Gynaecologists, 
Royal  College  of  Physicians  of  Ireland  and  Directorate  of  Strategy  and  Clinical  Programmes,  Health  Service Executive
7 The WHO application of ICD-10 to deaths during pregnancy, childbirth and puerperium: ICD MM. World Health Organisation 2012
8 Evaluating the quality of care for severe pregnancy complications. The WHO near-miss approach for maternal health. World Health 
Organization; 2011
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Further analysis was conducted to assess 
variation in incidence rates between years, 
maternal age groups, and single and multiple 
pregnancies. This analysis involved using 
Poisson regression which calculates a rate 
ratio (for example, the rate in one year 
divided by the rate in the previous year). 
Rate ratios have the advantage of being easy 
to interpret. A rate ratio is greater than one if 
a rate is greater than the rate to which it is 
being compared. For example a rate ratio of 
1.25 indicates the rate being examined is 25% 
higher than (or 1.25 times) the rate to which it 
is being compared. Conversely, a rate ratio will 
be less than one if a rate is less than the rate 
to which it is being compared. For example a 
rate ratio of 0.80 indicates that the rate being 
examined is equivalent to 80% of the rate to 
which it is being compared, i.e. it is 20% lower. 
The Poisson regression analysis provides 
a 95% confidence interval for the rate ratio 
and the associated p-value, both of which 
indicate whether the rate difference is in line 
with what might be expected due to chance. 
A rate difference is considered to be beyond 
what might be expected by chance, i.e. 
statistically significant, if the 95% confidence 
interval for the rate ratio does not include the 
value one. This is equivalent to the p-value 
derived from the analysis being less than 
0.05. If the p-value is less than 0.001 then 
the rate difference may be considered highly 
statistically significant.
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Main Findings
The eighteen participating maternity units 
reported that 365 women experienced SMM in 
2014, as defined in this audit. Table 1 details 
the number of cases, total maternities and SMM 
rates derived from the participating units in each 
of the four years of the audit, 2011-2014.
From 2011 to 2014, the SMM rate varied 
from 3.83 to 5.93 per 1,000 maternities or 
from one in 260 maternities to one in 170 
maternities. Respectively, the SMM rate 
was 16%, 24% and 55% higher in 2012, 2013 
and 2014 than in the base year 2011. This is 
equivalent to an annual rate increase of 15% 
(annual rate ratio=1.15, 95% CI=1.09-1.21, 
p-value<0.001). While four years is a short 
time period to establish trends, this extent of 
increase is beyond expected yearly variation. 
Some of this increase may be attributable to 
improvements in case ascertainment. 
The most recent data from the 
methodologically comparable national audit 
in Scotland reported an SMM rate of 7.3 per 
1,000 maternities for 2012. The Irish SMM 
rate for 2014 is almost 20% lower than the 
most recent Scottish rate (rate ratio=0.81, 
95% CI=0.71-0.93, p-value=0.004).
National rate
Table 1: Incidence of severe maternal morbidity (SMM) in Ireland, 2011-2014
Note: 95% CI=95% confidence interval. * Cases of uterine rupture exclusive of major obstetric haemorrhage were not reported for 2011.
2011* 2012 2013 2014
Maternities in participating units 67,806 65,768 68,047 61,593
SMM cases 260 292 323 365
SMM rate 3.83 4.44 4.75 5.93
(95% CI) (3.36-4.31) (3.92-4.96) (4.22-5.27) (5.31-6.54)
Rate ratio 1.00 1.16 1.24 1.55
(95% CI) (Ref.) (0.98-1.37) (1.05-1.46) (1.32-1.81)
p-value 0.086 0.011 <0.001
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Almost three quarters of the women (n=262, 
71.8%) who experienced SMM in 2014 were 
diagnosed with one SMM; 23% (n=83, 22.7%) 
were diagnosed with two morbidities; 4% 
(n=15, 4.1%) with three morbidities; and 1% 
(n=5, 1.4%) with four morbidities.
In the first three years of the NPEC SMM audit, 
MOH was the most frequently reported SMM 
event. This changed in 2014, when admission 
to an intensive or coronary care unit (ICU/CCU) 
was marginally more often reported. ICU/CCU 
admission and MOH were reported for almost 
half of the SMM cases in 2014 (Table 2).
The incidence of MOH was 2.76 per 1,000 
maternities in 2014. The equivalent incidence 
of MOH for the most recent year with data 
in Scotland (2012) was 5.8 per 1,000 
maternities (95% CI=5.2-6.5), more than 
twice the Irish rate.
The national audit in Scotland showed that 
their increasing incidence of SMM over the past 
decade was due to an increase in MOH. The NPEC 
previously showed that Ireland experienced an 
increasing trend in postpartum haemorrhage 
between the years 1999 to 2009.9
Table 2: Incidence of specific severe maternal morbidities (SMMs) in Ireland, 2011-2014
2011-2013 2014
n(%) Rate(95% CI) n(%) Rate(95% CI)
ICU/CCU admission 372(42.5) 1.85(1.65-2.04) 172(47.1) 2.79(2.37-3.22)
Major obstetric haemorrhage 500(57.1) 2.48(2.26-2.70) 170(46.6) 2.76(2.34-3.18)
Renal or liver dysfunction  69(7.9) 0.34(0.26-0.42) 40(11.0) 0.65(0.44-0.85)
Peripartum hysterectomy 65(7.4) 0.32(0.24-0.40) 21(5.8) 0.34(0.19-0.49)
Septicaemic shock 24(2.7) 0.12(0.07-0.17) 21(5.8) 0.34(0.19-0.49)
Pulmonary embolism 48(5.5) 0.24(0.17-0.31) 17(4.7) 0.28(0.14-0.41)
Acute respiratory dysfunction 14(1.6) 0.07(0.03-0.11) 14(3.8) 0.23(0.11-0.35)
Uterine rupture 24(2.7) 0.18(0.11-0.25) 9(2.5) 0.15(0.05-0.24)
Eclampsia 36(4.1) 0.18(0.12-0.24) 8(2.2) 0.13(0.04-0.22)
Pulmonary oedema 29(3.3) 0.14(0.09-0.20) 5(1.4) 0.08(0.01-0.15)
Anaesthetic problem 15(1.7) 0.07(0.04-0.11) 5(1.4) 0.08(0.01-0.15)
Cerebrovascular event 13(1.5) 0.06(0.03-0.10) 5(1.4) 0.08(0.01-0.15)
Cardiac arrest 15(1.7) 0.07(0.04-0.11) 2(0.5) 0.03(0-0.08)
Interventional radiology 24(2.7) 0.12(0.07-0.17) 2(0.5) 0.03(0-0.08)
Status epilepticus 3(0.3) 0.01(0-0.03) 2(0.5) 0.03(0-0.08)
Coma 0(0) 0(0-0) 0(0) 0(0-0)
Total women affected 875(100) 4.34(4.05-4.63) 365(100) 5.93(5.31-6.54)
Note: n represents number of women affected by the specific morbidity; % is based on the total number of women affected; rate is per 1,000 maternities; 95% 
CI=95% confidence interval; ICU=intensive care unit; Uterine rupture was not recorded by the audit in 2011 unless associated with MOH.
Specific morbidities
9 Lutomski J et al. Increasing trends in atonic postpartum haemorrhage in Ireland: an 11-year population-based cohort study. BJOG 2012; 
119: 306-14.
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An increasing number of MOH cases has been 
reported to this audit over the four-year period 
2011-2014 (Table 2; Figure 1).
The incidence of MOH cases increased from 
2.34 per 1,000 maternities in 2011 to 2.76 per 
1,000 in 2014, an overall increase of 18% (rate 
ratio=1.18, 95% CI=0.95-1.46, p-value=0.140), 
which is not beyond what might be expected in 
variation of rates of such magnitude. However, the 
incidence of maternity admissions into an ICU/
CCU has increased by 70% during 2011-2014 (rate 
ratio=1.71, 95% CI=1.34-2.17, p-value<0.001). 
Figure 1 illustrates the trend in the rate of SMM as 
defined in this audit and the separate trends for 
MOH and ICU/CCU admission.
There were 40 reported cases involving renal or 
liver dysfunction in 2014 (Table 2). The incidence 
rate of 0.65 per 1,000 maternities was twice the 
rate of 0.34 per 1,000 in 2011-2013. There were 
21 reported cases of peripartum hysterectomy 
(PH) in 2014. The national PH rate in Ireland is 
consistently around 0.34 per 1,000 maternities 
or approximately one in every 3,000 maternities. 
This rate is similar to national rates reported in the 
UK and the Netherlands of 0.41 and 0.33 per 1,000 
births respectively .10,11
Recent reports on maternal mortality in 
Ireland and the UK have identified thrombosis/
thromboembolism as a leading direct obstetric 
cause of maternal death. At 0.28 per 1,000 
maternities or one in 3,600 women, the incidence 
of pulmonary embolism (PE) in 2014 was the 
same as in 2012/2013. We believe this may be an 
underestimate as many post-natal cases will be 
unknown to maternity units when women present 
to a general hospital.
There were 21 cases of septic shock reported for 
2014, a small increase on the 16 cases reported for 
2013. These numbers are in contrast with the four 
reported cases in each of the first two years of the 
audit. This may be a true increase in incidence or 
may be associated with an increased awareness 
and recognition of sepsis. While the number of 
cases was small, there were 14 cases of acute 
respiratory dysfunction reported in 2014, the same 
as the number reported in the preceding three 
years.
Table 3 details the specific SMMs involved in the 172 
cases admitted into an ICU/CCU. One in four of these 
cases involved MOH (26.2%), 8.1% involved acute 
respiratory dysfunction, 5.8% involved peripartum 
hysterectomy and 5.8% involved septic shock.
It is notable that half of the women admitted into 
an ICU/CCU in 2014 had not experienced a severe 
morbidity as defined in this audit (47.7%, n=82 of 
172). This phenomenon has increased over the four 
Figure 1: Trend in the rate of severe maternal morbidity (SMM), major obstetric haemorrhage 



























10 Knight M, Kurinczuk JJ, Spark P and Brocklehurst P. United Kingdom Obstetric Surveillance System
(UKOSS) Annual Report 2007. National Perinatal Epidemiology Unit, Oxford.
11 Kwee A, Bots ML, Visser GH, Bruinse HW. Emergency peripartum hysterectomy:a prospective study in The Netherlands. Eur 
J Obstet Gynecol Reprod Biol 2006;124(2):187–92
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Nine of the 18 units that participated in the 
SMM audit also classified their deliveries into 
one of ten groups, as per the Robson Ten Group 
Classification System12 (Appendix F). The 
45,543 deliveries in these units constituted 
three quarters (73.9%) of the 61,593 
deliveries in the 18 units that participated 
in the SMM audit. The incidence of MOH and 
of SMM, excluding the criteria for MOH, in 
the nine maternity units submitting Robson 
Classification data is detailed in Table 4.
For the nine units, the MOH rate was 2.4 per 
1,000 deliveries and the rate of other SMM was 
1.8 per 1,000. Notwithstanding the relatively 
small numbers involved when examining 
by Robson Group, there was evidence of 
increased risk of MOH in Group 8 (women with 
multiple pregnancies) and increased risk of 
SMM, excluding the criteria for MOH, in Group 
10 (women with premature deliveries).
Variation by Robson Classification
Table 3: Specific severe maternal morbidities (SMMs) associated with admission to an intensive 
care unit or coronary care unit (ICU/CCU) in Ireland, 2014
n(%)
Major obstetric haemorrhage (MOH) 45(26.2)
Acute respiratory dysfunction  14(8.1)
Peripartum hysterectomy 10(5.8)
Septicaemic shock  10(5.8)
Renal or liver dysfunction 9(5.2)
Uterine rupture 5(2.9)
Cerebrovascular event  5(2.9)
Eclampsia  4(2.3)
Pulmonary embolism  3(1.7)
Pulmonary oedema  3(1.7)
Anaesthetic problem  2(1.2)
Cardiac arrest  1(0.6)
Interventional radiology 1(0.6)
Status epilepticus 1(0.6)
None of the above 82(47.7)
Total women admitted to ICU/CCU 172(100)
Note: n represents number of women affected by the specific morbidity; % is based on the total number of women admitted 
to ICU/CCU in 2014. 
years of the audit. The proportion of cases admitted 
to an ICU/CCU with no associated severe morbidity 
was 25% in 2011; 35% in 2012; 41% in 2013; and 
48% in 2014 (2011: n=28 of 111, 25.2%; 2012: 
n=46 of 130, 35.4%; 2013: n=53 of 131, 40.5%).
Half (n=42, 51.2%) of these cases occurred in three 
small maternity units with on-site ICU facilities 
but without obstetric high dependency facilities. 
Feedback from these units indicated that the rate 
of such ICU/CCU admissions reflected resource 
issues in cases where women required a higher 
level of monitoring. In these three units, more than 
half of the 42 ICU admissions with no other SMM as 
defined in this audit required Level 2 Care (n=23, 
54.8%) and the other 19 cases required Level 1 
Care (45.2%).
12 Robson MS (2001). Classification of caesarean sections. Fetal and Maternal Medicine Review, 12, pp 23-39 doi:10.1017/
S0965539501000122. 
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Note: CS=Caesarean section; *Other SMM excludes cases of MOH and cases of ICU admission only; Robson Group could not be determined for 16 MOH cases and 
Note: CS=Caesarean section; *Other SMM excludes cases of MOH and cases of ICU admission only; Robson Group could not be determined for 16 MOH cases and 
13 cases of other SMM. 
Table 4: Incidence of major obstetric haemorrhage (MOH) and severe maternal morbidity (SMM) excluding MOH 
by Robson Group in nine Irish maternity units, 2014 
Group Group description Deliveries Delivered 
by CS
MOH Other SMM*
N % n(%) Rate n(%) Rate
All 45,543 29.5 111(100%) 2.4 82(100%) 1.8
1 Nulliparous, singleton, 
cephalic, >37/40, 
spontaneous labour
8,520 12.0 19(17.1%) 2.2 5(6.1%) 0.6
2 Nulliparous, singleton, 
cephalic, >37/40 induced 
or elective CS
7,367 40.6 22(19.8%) 3.0 13(15.9%) 1.8
3 Multiparous (excluding 
previous CS), singleton, 
cephalic, >37/40, 
spontaneous labour
11,886 2.1 9(8.1%) 0.8 3(3.7%) 0.3
4 Mulitparous (excluding 
previous CS), singleton, 
cephalic, >37/40 induced 
or elective CS
6,578 14.6 15(13.5%) 2.3 5(6.1%) 0.8
5 Previous CS, singleton, 
cephalic, >37/40, induced 
or elective CS
6,411 77.0 15(13.5%) 2.3 15(18.3%) 2.3
6 All nulliparous women 
with a single breech 
pregnancy
936 96.6 3(2.7%) 3.2 6(7.3%) 6.4
7 All multiparous breech 
(including previous CS) 816 91.4 3(2.7%) 3.7 1(1.2%) 1.2
8 All multiple pregnancies 
(including previous CS) 950 69.5 17(15.3%) 17.9 4(4.9%) 4.2
9 All women with a single 
pregnancy with a 
transverse or oblique lie, 
including women with 
previous uterine scars
181 83.4 1(0.9%) 5.5 2(2.4%) 11.0
10 All singleton, cephalic, 
<36/40 (including 
previous CS)
1,898 42.7 7(6.3%) 3.7 28(34.1%) 14.8
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Number of maternities in 2014
Unit SMM rate National SMM rate 95% CI
Variation in the 2014 SMM rate across the 
participating eighteen maternity units is 
illustrated in the funnel plot in Figure 2. The 
solid line represents the national SMM rate 
(5.93 per 1,000 maternities). The dashed lines 
represent the limits of the 95% confidence 
interval around the national rate. These 
limits are adjusted according to the number 
of maternities at each unit and are wider for 
smaller units reflecting the greater volatility 
in rates based on small numbers. Being 95% 
confidence limits, we can expect, on average, 
one in twenty units to have a rate outside the 
dashed lines. However, differences between 
units must be interpreted with caution as they 
may not reflect care given but could reflect 
differences in levels of reporting and/or 
differences in the risk profile of the pregnant 
women presenting to the units.
Variation in rates by maternity unit
From Figure 2, it can be seen that three units 
have an outlying SMM rate above the 95% 
confidence interval upper limit. The rate for 
one of these units is three times the national 
rate (18.27 vs. 5.93 per 1,000 maternities). 
The rate for the other two units is almost twice 
the national rate (9.94 and 10.99 per 1,000).
The majority of the SMM cases for the most 
outlying unit (n=23 of 33, 69.7%) were 
reported because they met the SMM criterion 
of being admitted to an ICU/CCU with no other 
SMM experienced as defined in this audit. 
These are patients requiring monitoring above 
normal ward standard and due to low levels of 
staff in the unit, this could only be achieved 
by admission to the ICU.
It can also be seen from Figure 2 that one of 
the country’s four large maternity hospitals 
had a SMM rate below the lower limit of 
the confidence interval. At 3.30 per 1,000 
maternities, the rate for this unit was just over 
half the national rate.
The funnel plot in Figure 3 illustrates the 
variation in the SMM rate by maternity unit 
after exclusion of cases admitted to an ICU/
CCU with no other SMM experienced as defined 
in this audit. The adjusted national SMM rate 
was 4.59 per 1,000 maternities. The plot 
shows one notable outlying unit with a rate of 
8.77 per 1,000, almost twice the national rate.
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Figure 3: Funnel plot of the rate of severe maternal morbidity (SMM) by maternity unit excluding 
cases admitted to an ICU/CCU with no other SMM experienced as defined in this audit, 2014 




























Number of maternities in 2014



























Number of maternities in 2014
Unit MOH rate National MOH rate 95% CI
Figure 4 illustrates variation in the rate of MOH 
across the eighteen participating maternity 
units in 2014. Three units had a rate above the 
upper limit of the confidence interval for the 
national rate of 2.76 per 1,000 maternities. 
The MOH rate for each of these units (5.64, 
6.28 and 7.02 per 1,000) was at least twice 
the national rate.
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Number of maternities in 2011-2014
Unit MOH rate National MOH rate 95% CI
Based on the four years of data from the SMM 
audit (2011-2014), we calculated the average 
rate of MOH for the eighteen maternity units 
that participated in 2014 (Figure 5). The 95% 
confidence interval around the national rate 
for this four-year period is narrower than in the 
annual funnel plots, a result of the increased 
numbers involved.
The plot shows evidence of excessive 
variation in the MOH rate across the 18 units, 
with the rate for seven units lying outside the 
limits of the confidence interval (four above 
the upper limit and three below the lower 
limit). Variances in rates of MOH between 
units may reflect variances in practices of 
estimating blood loss. A quantitative approach 
involving volume and weight assessment to 
estimate blood loss should be considered for 
use in all maternity units. Development of a 
national tool-kit would assist standardisation 
of such an approach. We recommend the 
development and national implementation of 
a specific proforma to improve management 
and documentation during a major obstetric 
haemorrhage event, whether in the antenatal 
or postnatal period.
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Age group SMM SMM SMM All maternities SMM rate Rate ratio
2012 2013 2014 2014 2014 (95% CI)
(N=283) (N=319) (N=363)* (95% CI)
<20yrs 3(1.0) 6(1.9) 5(1.4) 1.9% 4.35 0.93
(0.47-8.23) (0.37-2.31)
20-24yrs 14(4.8) 20(6.2) 33(9.1) 8.8% 6.07 1.29
(3.96-8.17) (0.84-1.98)
25-29yrs 60(20.5) 44(13.6) 57(15.7) 19.7% 4.69 1.00
(3.45-5.93) (Ref.)
30-34yrs 88(30.1) 118(36.5) 126(34.7) 36.7% 5.55 1.18
(4.57-6.54) (0.87-1.62)
35-39yrs 97(33.2) 100(31.0) 110(30.3) 26.8% 6.63 1.41
(5.37-7.89) (1.03-1.95)
≥40yrs 30(10.3) 35(10.8) 32(8.8) 6.1% 8.49 1.81
(5.50-11.48) (1.17-2.79)
Note: Values are shown as n(%) unless otherwise stated. Data for all maternities are from Perinatal Statistics Report 2014. 
Healthcare Pricing Office (HPO). Dublin: HPO, 2016. SMM rate per 1,000 births. * Maternal age was not known for two women. 
Table 5: Age distribution of women who experienced severe maternal morbidity (SMM) in 2012-2014
Age
Maternal age, recorded for 363 of the 365 
cases of severe maternal morbidity (SMM) in 
2014, ranged from 17 to 45 years. The average 
age was 33 years (standard deviation = 6 
years). The age distribution of women who 
experienced SMM in 2012-2014 is detailed in 
Table 5. In 2014, 65% were aged 30-39 years 
which was similar to the population of women 
who gave birth in 2014. Women aged 35 years 
or over were somewhat overrepresented: they 
accounted for 39.1% of SMM cases in 2014 
compared to 32.9% of the population who gave 
birth that year. This is reflected in the SMM 
rate calculated by maternal age based on data 
for 2014 (Table 5), whereby the highest SMM 
rate was among 35-39 year-olds and women 




There are no national data available on 
ethnicity for the pregnant population in 
Ireland. The distribution by ethnic group of the 
women who experienced SMM in 2014 broadly 
reflected that of the general population of 
women aged 15-49 years as reported from 
the most recent national census (Table 6). 
However, 69.9% were of white Irish ethnicity, 
lower than the 80.4% reported as white Irish 
by the census.13 In those who experienced 
SMM there was an overrepresentation of 
women whose ethnicity was described as 
Asian or Black as they made up 9.4% of SMM 
cases but only 4.0% of the population aged 15-
49 years.
Body mass index
Body mass index (BMI) for the women who 
experienced SMM in 2014 ranged from 17 to 
48kgm-2. BMI was not known for 44 (12.1%) 
of the women. This level of reporting of BMI is 
similar to that for SMM cases in 2012 and 2013. 
Less than half of the women who experienced 
SMM had a BMI in the normal range, one third 
were overweight and one in four were obese 
(Table 7). This BMI profile closely matches that of 
the women in the 2015 Healthy Ireland Survey.14 
However, interpretation of this comparison must 
consider the weight gain due to pregnancy for 
the women who experienced SMM as the Healthy 
Ireland Survey was of the general population. 
However, there are no national data available on 
BMI for the pregnant population.
SMM 15-49 year-old
2014 female population, 2011
(N=365) % 
White Irish 254(69.6) 80.4
Irish Traveller 10(2.7) 0.7
Other white background 51(14.0) 12.5
Asian/Asian Irish 21(5.8) 2.4
Black/Black Irish 13(3.6) 1.6
Other/mixed 1(0.3) 1.0
Not recorded 15(4.1) 1.4
BMI category (kgm-2) SMM Healthy Ireland
2014 Survey 2015
(N=321)* %
Underweight (<18.5) 4(1.2) 3
Healthy (18.5-24.9) 134(41.7) 44
Overweight (25.0-29.9) 105(32.7) 31
Obese (≥30.0) 78(24.3) 22
Note: Values are shown as n(%) unless otherwise stated.
Note: Values are shown as n(%) unless otherwise stated. * BMI was not known for 44 women.
Table 6: Ethnicity of women who experienced severe maternal morbidity (SMM) in 2014
Table 7: Body mass index (BMI) of women who experienced severe maternal morbidity (SMM) in 2014
13 Central Statistics Office. Profile 7 Religion, Ethnicity and Irish Travellers. 2012. Dublin: The Stationary Office. 
14 Ipsos MRBI (2015). Healthy Ireland Survey 2015. Dublin: The Stationery Office.
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Smoking, alcohol and drug misuse
Smoking status at the time of the first hospital 
booking appointment was not known for 
16% of the women (n=60, 16.4%). Of the 
remainder, one in seven were reported to 
have been smoking at the time of the first 
booking (46 of 305, 15.1%). The prevalence 
of smoking during pregnancy is not routinely 
published for all Irish pregnancies but rates 
of 12%, 15%, 16% and 19% have been reported 
for England, Northern Ireland, Wales and 
Scotland, respectively.15
The quantity smoked was recorded for 36 of 
the 46 women who were smokers at the time 
of the first hospital booking appointment. On 
average, they smoked 10 cigarettes per day, 
ranging  from three to 20. Fifteen women were 
reported to have given up smoking during 
their pregnancy, five before and ten after their 
first hospital booking appointment.
Alcohol drinking status at the time of the first 
hospital booking appointment was not known 
for 29% of the women (n=105, 28.8%). Of 
the 260 women with available data, only 8% 
were reported to be drinking alcohol (n=21, 
8.1%). Six women (1.7%) were recorded as 
having a documented history of drug abuse or 
attendance at a drug rehabilitation unit.
Previous pregnancy
Just over forty percent (42.3%) of the 
women who experienced SMM in 2014 were 
nulliparous which is in line with previous 
years (Table 8). Women who had had one 
previous completed pregnancy, i.e. para 
1, were underrepresented among the SMM 
cases when compared with the population 
of women birthing in Ireland in 2014 (28.1% 
versus 34.5%). As a corollary, women of 
higher parity and nulliparous women were 
slightly overrepresented among the SMM 
cases compared with the overall population.
Previous early pregnancy loss was reported 
for 30% of the women who experienced 
SMM in 2014 (107 of 359, 29.8%; unknown 
for six women). Twenty-two women (6.1%) 
had previously experienced three or more 
pregnancies that ended before 24 weeks 
gestation.
One in four of the women who experienced 
SMM in 2014 had a previous caesarean section 
delivery (n=85 of 338, 25.1%; unknown for 
27 women). The prevalence of a previous 
caesarean section was over 40% among the 
women who had previously given birth (n=85 
of 193, 44.0%; not known for 14 women).
15 EURO-PERISTAT Project with SCPE and EUROCAT. European Perinatal Health Report. The health and care of pregnant women 
and babies in Europe in 2010. May 2013. Available www.europeristat.com
Parity SMM  SMM SMM All maternities
2012 2013 2014 2014
(N=288)* (N=321)* (N=359)* 
Nulliparous 119(41.3) 122(38.0) 152(42.3) 38.6%
Para 1 88(30.6) 97(30.2) 101(28.1) 34.5%
Para 2 43(14.9) 55(17.1) 67(18.7) 17.7%
Para 3+ 38(13.2) 47(14.6) 39(10.9) 9.2%
Table 8: Distribution of parity for women who experienced severe maternal morbidity (SMM) in 
2012-2014
Note: Values are shown as n(%) unless otherwise stated; * Parity was not known for four, two and six cases in 2012, 2013 and 
2014, respectively. Data for all maternities are from Perinatal Statistics Report 2014. Healthcare Pricing Office (HPO). Dublin: 
HPO, 2016
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Early pregnancy loss (before 24 weeks 
gestation and birthweight less than 
500g) was experienced by 18 of the 
365 women (4.9%). These involved 12 
cases of miscarriage (3.3%), five cases of 
ectopic pregnancy (1.4%) and one medical 
termination of pregnancy (0.3%). MOH was 
associated with seven of the 18 cases of 
early pregnancy loss (four of the five cases of 
ectopic pregnancy and three miscarriages). 
There were six cases of septicaemic 
shock, all associated with miscarriage. The 
reported SMM for the remaining five cases 
of early pregnancy loss was uterine rupture 
(n=1), cerebrovascular event (n=1) and ICU 
admission (n=3).
Of the 347 women whose SMM was not 
associated with early pregnancy loss, 24 
had a multiple birth (n=24 of 338, 7.1%; 
unknown for nine women; Table 10). All 24 
multiple births involved twins. In Ireland 
in 2014, multiple births made up 1.9% of all 
maternities (n=1,202 of 61,779 in maternity 
units participating in this audit). Thus, 
multiple pregnancy was almost four times 
more common in cases of SMM than in all 
maternities, a reflection of the increased risk 
of SMM associated with multiple pregnancy. 
This is evident from the national SMM rate of 
5.2 per 1,000 maternities associated with 
singleton pregnancy in 2014 and a four times 
higher rate of 20.0 per 1,000 maternities for 
multiple pregnancy (p-value<0.001). 
These findings are similar to findings from 
Scotland where 6.4% of SMM cases with 
available data in 2012 were associated with 
twin pregnancies, four times higher than 
their proportion of twin births in 2012 (1.5%).
For 9% of the women who experienced SMM 
in 2014, their pregnancy was the result of 
infertility treatment (n=28 of 319, 8.8%; 
unknown for 46 women). In half of these 
cases the method of infertility treatment was 
in vitro fertilisation (n=14 of 28, 50.0%).
Gestation at delivery or pregnancy end ranged 
from six to 42 weeks. For almost two thirds of 
the women affected (64.0%), their pregnancy 
went full term (Table 9). For a further 22.3%, 
their pregnancy ended at moderate to late 
pre-term gestation (32-36 weeks). For 4% of 
the women, the end of pregnancy occurred 
before 22 weeks gestation.
2012 2013 2014
(N=287)* (N=317)* (N=350)*
Pre-viable (<22wks) 15(5.2) 11(3.5) 14(4.0)
Extremely pre-term (22-27wks) 4(1.4) 15(4.7) 14(4.0)
Very pre-term (28-31wks) 22(7.7) 14(4.4) 19(5.4)
Moderate/late pre-term (32-36wks) 50(17.4) 73(23.0) 78(22.3)
Term (37-41wks) 192(66.9) 204(64.4) 224(64.0)
Post-term (42wks+) 4(1.4) 0(0.0) 1(0.3)
Table 9: Gestation at delivery or pregnancy end for women who experienced severe maternal 
morbidity in 2012-2014
Note: Values are shown as n(%) unless otherwise stated; * Gestation was not known for five, six and 15 cases in 2012, 2013 and 
2014, respectively.
Pregnancy associated with the severe maternal morbidity event
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SMM SMM SMM All SMM rate Rate ratio
2012 2013 2014 maternities (95% CI) (95% CI)
(N=292) (N=323) (N=338)* 2014 
Single 273(93.5) 296(91.6) 314(92.9) 98.1% 5.18 1.00
(4.60-5.77) (Ref.)
Multiple 19(6.5) 27(8.4) 24(7.1) 1.9% 19.97 3.85
 (11.90-28.04) (2.54-5.83)
Table 10: Single and multiple birth for women who experienced severe maternal morbidity (SMM) in 
2012-2014
Note: Data for all maternities are from Perinatal Statistics Report 2014. Healthcare Pricing Office (HPO). Dublin: HPO, 2016. Values 
are shown as n(%) unless otherwise stated. SMM rate per 1,000 births. *Not known for nine of the 347 women in 2014 whose SMM 
was not associated with early pregnancy loss.
Mode of delivery
The mode of delivery for two thirds of the 
women who experienced SMM in 2014 was 
caesarean section (Table 11). This is over twice 
the 30% caesarean section rate occurring in 
all births nationally in 2014. The majority of 
caesarean sections in cases of SMM were 
carried out prior to labour which may reflect 
the clinical complexity of the pregnancy rather 
than mode of delivery influencing risk of SMM. 




Vaginal 82(29.8) 102(33.0) 114(33.8)
 Spontaneous 56(20.4) 73(23.6) 67(19.9)
Assisted breech 2(0.7) 3(1.0) -
 Ventouse 10(3.6) 16(5.2) 25(7.4)
Non-rotational forceps 14(5.1) 10(3.2) 18(5.3)
Rotational forceps - - 4(1.2)
Caesarean section 193(70.2) 207(67.0) 223(66.2)
Elective LSCS (no labour) 64(23.3) 59(19.1) 54(16.0)
Elective LSCS (labour) 5(1.8) 5(1.6) 7(2.1)
Emergency LSCS (no labour) 52(18.9) 77(24.9) 99(29.4)
Emergency LSCS (labour) 71(25.8) 63(20.4) 61(18.1)
 Classical 1(0.4) 3(1.0) 25(7.4)
Note: Values shown are n(%) unless otherwise stated; * Mode of delivery was not known for one, two and ten cases in 2012, 
2013 and 2014, respectively. For cases of multiple birth when mode of delivery differed for the babies, the more complex mode 
of delivery was taken as the primary mode. LSCS=Lower segment caesarean section. Data excludes 16, 12 and 18 cases of 
early pregnancy loss in 2012, 2013 and 2014, respectively.
Table 11: Primary mode of delivery (of babies weighing ≥500g or ≥24 weeks gestation) for 
women who experienced severe maternal morbidity in 2012-2014
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Maternal care details
For the first time this audit recorded level of 
maternal care provided. Virtually all of the 
women who experience SMM in 2014 required 
an increased level of support/critical care 
(Table 12). Over one third required Level 1 
Care, half required Level 2 Care and one in ten 
required Level 3 Care
Note: Level of Care not known for 15 of the 365 women.
Note: Level of Care not known for 15 women; ICU=intensive care unit.
Table 12: Level of maternal care provided to women during clinical SMM events in Ireland in 2014
Table 13: Level of maternal care provided to women during specific clinical SMM events in Ireland in 2014
Level of Care Definition n(%)
Level 0:
Normal ward care
Care of low risk pregnant women 5
(1.4%)
Level 1:
Additional monitoring or 
intervention, or step down 
from higher level of care
Patients at risk of their condition deteriorating and 
needing a higher level of observation or those recently 





Patients requiring invasive monitoring/ intervention 
including support for a single failing organ system (incl. 






support alone, or support of 
two or more organ systems
Patients requiring advanced respiratory support 
(mechanical ventilation) alone or basic respiratory 




N(%) Level 0 Level 1 Level 2 Level 3
ICU/coronary care unit 
admission 166(47.4) - 48(28.9) 82(49.4) 36(21.7)
Major obstetric haemorrhage 162(46.3) 3(1.9) 67(41.4) 83(51.2) 9(5.6)
Renal or liver dysfunction 39(11.1) - 10(25.6) 23(59.0) 6(15.4)
Septicaemic shock 20(5.7) - 3(15.0) 11(55.0) 6(30.0)
Peripartum hysterectomy 19(5.4) - 3(15.8) 11(57.9) 5(26.3)
Pulmonary embolism 14(4.0) 2(14.3) 7(50.0) 5(35.7) -
Acute respiratory dysfunction 14(4.0) - - - 14(100.0)
Uterine rupture 8(2.3) - 4(50.0) 3(37.5) 1(12.5)
Eclampsia 8(2.3) - - 5(62.5) 3(37.5)
Pulmonary oedema 5(1.4) - - 2(40.0) 3(60.0)
Anaesthetic problem 5(1.4) - 2(40.0) 3(60.0) -
Cerebrovascular event 5(1.4) - 1(20.0) - 4(80.0)
Cardiac arrest 2(0.6) - - - 2(100.0)
Interventional radiology 2(0.6) - - 1(50.0) 1(50.0)
Status epilepticus 1(0.3) - -  1(100.0) -
Total 350(100) 5(1.4%) 125(35.7%) 181(51.7%) 39(11.1%)
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Of the women admitted to an ICU/CCU, 20% 
required Level 3 Care; half required Level 2 
Care; and 30% required Level 1 Care (Table 13). 
This highlights that admission to an ICU/CCU 
does not infer that a woman has a requirement 
for Level 3 Care. Of the 48 women who were 
admitted to an ICU/CCU and required Level 1 
Care only, 60% (n=29, 60.4%) did not experience 
another SMM as defined by this audit.
For MOH, cases were almost evenly 
distributed between Level 1 Care and Level 2 
Care, with six percent requiring Level 3 Care. 
As expected clinically, higher levels of critical 
care/monitoring were required for the women 
experiencing life-threatening maternal 
morbidities, e.g. cerebrovascular events, 
eclampsia and cardiac arrest.
Neonatal outcomes
Of the 347 women whose SMM was not 
associated with early pregnancy loss, 314 were 
reported to have given birth to a singleton and 
24 gave birth to twins (data were not known for 
nine women). Thus, a total of 362 babies were 
delivered. Information on neonatal outcome 
in terms of perinatal death was available for 
347 (95.9%) of these infants. There were 14 
stillbirths and six early neonatal deaths and no 
known late neonatal deaths.
The 20 perinatal deaths were associated with 
the delivery of 19 women. Gestation at delivery 
was extremely pre-term (22-27 weeks) for six 
women (31.6%), it was pre-term (28-36 weeks) 
for four women (21.1%) and occurred at term 
(37-41 weeks) for nine women (47.4%). Major 
obstetric haemorrhage affected two-thirds of 
the 19 women (n=12, 63.2%).
The perinatal mortality rate based on the 20 
stillbirths and early neonatal deaths among 
the 347 infants was 57.6 per 1,000 births, i.e. 
approximately 6% or one in 17 of the infants 
died. This rate was eight times the perinatal 
mortality rate observed for all births in Ireland 
in 2014 (p-value<0.001; Table 14). However, 
the rate is in line with the perinatal mortality 
rate among infants born to women with SMM in 
Scotland in recent years, which ranged from 17 
to 64 per 1,000 maternities.16
16  Scottish Confidential Audit of Severe Maternal Morbidity: 9th Annual Report (2013). Available from:http://www.
healthcareimprovementscotland.org/our_work/reproductive,_maternal__child/programme_resources/scasmm.aspx
Approximately 8% of the 348 live born infants 
were intubated following delivery and almost 
half were transferred to the Special Baby Care 
Unit (SBCU) or Neonatal Intensive Care Unit 
(NICU; Table 15).
(N=348)
Intubation following delivery (%) 26(7.5)
Transfer to SBCU/NICU (%) 166(47.7)
Table 15: Selected neonatal outcomes in 2014
Note: SBCU=Special Baby Care Unit; NICU=Neonatal Intensive Care Unit.
Perinatal deaths Births PMR Rate ratio
(95% CI)  (95% CI)
All births 2014* 471 67,663 7.0 1.0
(6.3-7.6) (Ref.)
SMM 2014 20 347 57.6 8.3
(32.6-82.7) (5.3-13.0)
Table 14: Perinatal mortality among infants born to women with SMM in Ireland in 2014 compared 
to perinatal mortality among all infants born in Ireland in 2014
Note: PMR=perinatal mortality rate per 1,000 births; * Manning E, Corcoran P, Meaney S, Greene RA, on behalf of the Perinatal 
Mortality Group. Perinatal Mortality in Ireland Annual Report 2014. Cork: National Perinatal Epidemiology Centre, 2016.
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17 Clinical Practice Guideline No 30 (2014). Guideline for the Critically ill Woman in Obstetrics : Institute of Obstetricians and 
Gynaecologists,  Royal  College  of  Physicians  of  Ireland  and  Directorate  of  Strategy  and  Clinical  Programmes,  Health 
Service Executive
18 World Health Organisation, Evaluating the quality of care for severe pregnancy complications. The WHO near-miss approach 
for maternal health. World Health Organization; 2011
This section of the report presents findings 
from the audit of critical care in obstetrics in 
Ireland in 2014. Fifteen of the nineteen Irish 
maternity units have contributed data to this 
audit; two large tertiary referral maternity 
units and 13 smaller maternity units. 
The purpose of this audit was to address the 
dearth of national data on the prevalence 
rates for women who require Level 2 and 
Level 3 Care and the location where higher 
levels of care are provided. While all Level 3 
intensive care patients will be admitted to a 
Level 3 Care Unit and be readily identifiable 
in future national Intensive Care National 
Audit and Research Centre (ICNARC) data, 
estimation of the requirement for Level 
2 Care i.e. high dependency care, is more 
complicated.  Women requiring Level 2 
Care may have all or part of their critical 
care needs met in a maternity unit, but at 
the present time there is no national data 
recording this activity.
Levels of critical care
National and International guidelines 
have recommended that the terms high 
dependency and intensive care be replaced 
by the term critical care.17,18 The term critical 
care has a more precise definition whilst the 
terms maternal critical care, high dependency 
care and high risk maternity care are not 
interchangeable. Within the term critical care, 
care is subdivided into four levels, dependent 
on organ support and the level of monitoring 
required independent of clinical diagnosis 
(Appendix G).
Main findings
Overall, 244 women, out of 42,422 
maternities, required either Level 2 or Level 
3 Care (Table 16). This gives a rate of 5.75 
per 1,000 maternities or one in 174. Of these, 
220 women required Level 2 Care only (5.19 
per 1,000 maternities or one in 193) and 24 
women required Level 3 Care, either solely or 
in combination with Level 2 Care, during the 
clinical event (0.57 per 1,000 maternities or 
one in 1,768).
2. Confidential Audit of Critical Care in Obstetrics in Ireland
Level of Critical Care N(%) 
Level 2 Care only 220 (90.2%)
Level 2 followed by Level 3 Care 5 (2%)
Level 2 followed by Level 3 followed by Level 2 Care 3 (1.2%)
Level 3 Care only 9 (3.7%)
Level 3 followed by Level 2 Care 7 (2.9%)
Table 16: Sequence of critical care provided to women who required Level 2 or 3 Care in 2014
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Note: The duration of Level 2 Care was unknown for one woman who required Level 2 Care only.
Duration of critical care
The duration of Level 2 Care was known for 
219 of the 220 women who required Level 2 
Care only. The maximum duration of Level 2 
Care was 24 days and for the vast majority 
(91.8%), the duration of Level 2 Care did not 
exceed three days. Of the 24 women who 
required Level 3 Care, the maximum duration 
of Level 3 Care was 28 days. For the vast 
majority (79.2%), the duration of Level 3 Care 
did not exceed three days (Figure 6).






















Dura:on of cri:cal care (days) 
Level 2 only Level 3 
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Table 17: Body mass index (BMI) of women who required Level 2 or Level 3 Care in 2014
Note: Values are shown as n(%) unless otherwise stated. * BMI was not known for 25 women who required Level 2 or Level 3 
Care and 44 SMM cases.
Data on pre-existing co-morbidities was available 
for 218 of the 220 women who required Level 2 
Care only and all 24 women who required Level 
3 Care. Irrespective of level of care required, just 
over one third had pre-existing co-morbidities 
(Level 2 Care only: n=76, 34.9%; Level 3 Care: 
n=9, 37.5%; Figure 7).
The pregnancy risk level during the antenatal 
period was recorded for 210 of the 220 women 
requiring Level 2 Care only and 22 of the 24 
women requiring Level 3 Care. The pregnancy 
of nearly half the women (n=94, 44.8%) who 
required Level 2 Care only had been identified 
as high risk during the antenatal period. The 
pregnancy of nearly two-thirds of those 
(n=13, 59.1%) who required Level 3 Care 
had been identified as high risk antenatally 
(Figure 7).
Pre-existing co-morbidities and antenatal risk assessment
Figure 7: Pre-existing co-morbidities and antenatal risk assessment for women who required 
Level 2 and Level 3 Care in 2014
Maternal characteristics
Body mass index (BMI) for the women who 
required Level 2 or Level 3 Care in 2014 ranged 
from 18 to 48kgm-2. BMI was not known for 25 
of the women. Less than forty percent (38.4%) 
of the women had a BMI in the healthy range, 
30.6% were overweight and another 30.6% 
were obese (Table 17). This BMI profile closely 
matches that of all women who experienced 
SMM in 2014, as defined in the NPEC SMM 
audit, and of the general population of women 
sampled in the 2015 Healthy Ireland Survey.
BMI category 
(kgm-2)









Underweight (<18.5) 1(0.5) 4(1.2) 3
Healthy (18.5-24.9) 84(38.4) 134(41.7) 44
Overweight (25.0-29.9) 67(30.6) 105(32.7) 31
Obese (≥30.0) 67(30.6) 78(24.3) 22
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Multiple Pregnancies
Compared to the population of women 
who gave birth in 2014, there was an over-
representation of women with multiple 
pregnancies amongst those who required 
Level 2 or Level 3 Care (Table 19). 
Almost half of the women who required Level 
2 or Level 3 Care in 2014 were nulliparous 
(Table 18). This is slightly higher than was 
observed among all women who experienced 
SMM in 2014 and is higher than in the 
population of women who gave birth in 2014, 
thus nulliparous women are over-represented 
amongst those who required Level 2 or Level 3 
Care. The number of multiparous women who 
required Level 2 or Level 3 Care was broadly 
similar to the number who experienced SMM 
in 2014 and in the case of Para 2 and Para 3+ 
women, similar to the population who gave 
birth in 2014. 
Table 18: Distribution of parity for women who required Level 2 or Level 3 Care in 2014
Table 19: Single and multiple births in women who required Level 2 or Level 3 Care in 2014
Note: Values are shown as n(%) unless otherwise stated; * Parity was not known for five women who required Level 2 or Level 
3 Care and six SMM cases. Data for all maternities are from Perinatal Statistics Report 2014. Healthcare Pricing Office (HPO). 
Dublin: HPO, 2016
Note: Data for all maternities are from Perinatal Statistics Report 2014. Healthcare Pricing Office (HPO). Dublin: HPO, 2016. 
Values are shown as n(%) unless otherwise stated. *Not known for 14 women who required Level 2 or Level 3 Care and nine of 
the 347 women in 2014 whose SMM was not associated with early pregnancy loss.








Nulliparous 114(47.7) 152(42.3) 38.6%
Para 1 68(28.5) 101(28.1) 34.5%
Para 2 36(15.1) 67(18.7) 17.7%
Para 3+ 21(8.8) 39(10.9) 9.2%








Single 217(94.3) 314(92.9) 98.1%
Multiple 13(5.7) 24(7.1) 1.9%
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19 The WHO application of ICD-10 to deaths during pregnancy, childbirth and puerperium: ICD MM. World Health Organisation 2012
20 O’Malley E, Popivanov P, Fergus A and Byrne B. Maternal Near Miss: what lies beneath? European Journal Obstetric Gynaecology 
Reproductive  Biology 2016;199
Maternal morbidity in women requiring Level 2 Care
Maternal morbidity was classified as direct, 
indirect or coincidental based on the main 
clinical diagnosis during the critical care event, 
using the WHO classification for maternal 
mortality (Appendix I).19 Briefly described, 
direct maternal morbidities refer to obstetric 
complications of the pregnancy state while 
indirect maternal morbidities refer to medical 
complications resulting from pre-existing 
disease, or disease that developed during 
pregnancy which was not the result of direct 
obstetric causes, but which was aggravated 
by the physiological effects of pregnancy. The 
majority of women (91.4%) requiring Level 2 
Care in this audit were classified as having a 
direct obstetric morbidity; 8.2% had an indirect 
morbidity; and there was one case (0.5%) of 
coincidental morbidity (Table 20). The main 
causes of direct obstetric morbidity in women 
who required Level 2 Care were attributable to 
hypertensive disorders (52.3%) and obstetric 
haemorrhage (29.1%). 
The absence of international consensus on 
definitions of SMM is problematic and impedes 
comparative analysis and uniform case-
identification criteria. The WHO defines severe 
maternal complications as potentially life-
threatening conditions and a maternal near 
miss as a woman who nearly died but survived 
a complication during pregnancy, childbirth or 
within 42 days of termination of pregnancy. 
Table 20 demonstrates the number of maternal 
morbidities identified using three different 
definitions for maternal morbidity: the NPEC 
SMM, the WHO Severe Maternal Complication 
(SMC) criteria (Appendix J) and the WHO Near 
Miss (NM) criteria (Appendix K). Almost all 
(97.5%) direct causes of SMM satisfied the WHO 
SMC criteria, but only 17.9% fulfilled the WHO 
NM criteria and a further 10.9% had insufficient 
data to determine NM criteria. The majority 
(n=130, 64.7%) of direct morbidities fulfilled 
the NPEC SMM criteria, however, 39 (30.0%) 
of these cases fulfilled the criteria due to ICU 
admission only.
Considering the NPEC SMM and WHO NM 
definitions utilise organ dysfunction criteria, 
it is evident that a number of women 
requiring Level 2 Care do not experience 
organ dysfunction as their clinical needs were 
identified and treated before organ dysfunction 
occurred. This is similar to findings of a recent 
study of HDU admissions in a tertiary referral 
maternity unit in Ireland.20
Specific findings for women who required Level 2 Care only
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Table 20: Classification of maternal morbidity in women who required Level 2 Care in 2014 according to the NPEC 
Severe Maternal Morbidity (SMM), WHO Near Miss (NM) and WHO severe maternal complication (SMC) criteria.
Note: The superscripted number under the NPEC SMM categories column indicates the number of cases that fulfilled the criteria of the NPEC SMM audit due to 
ICU admission only. *Includes complications associated with early pregnancy loss (4 pregnancy related infections and 1 obstetric haemorrhage). ** For the 
WHO NM criteria, a range is provided: the lower figure indicates the number of cases which met the WHO NM definition and the higher number includes cases 
likely to have met the WHO NM definition but where extra data is required.






All (Direct, Indirect and Coincidental) 220 (100%) 139 (63.2%) 36-60 (16.4-27.3%) 204 (92.7%)
Direct 201 (91.4%) 130(64.7%) 39 36-58 (17.9-28.8%) 196 (97.5%)
Pregnancy with abortive outcome* 5 (2.3%) 4 (80%) None 1-4 (20-80%) 5 (100%)
Hypertensive disorders 115 (52.3%) 53 (46.1%) 29 5-13 (4.3-11.3%) 115 (100%)
Obstetric Haemorrhage 64 (29.1%) 62 (96.9%) 6 26-35 (40.6-54.7%) 63 (98.4%)
Pregnancy related infection 12 (5.5%) 6 (50.0%) 4 4-5 (33.3-41.6%) 12 (100%)
Other obstetric complications 3 (1.4%) 3 (100%) None 0 (0%) 1 (33.3%)
Unanticipated complications of 
management 2 (0.9%) 2 (100%) 
None 0-1 (0-50.0%) 0 (0%)
Indirect 18 (8.2%) 8 (44.4%) 4 0-2 (0-11.1%) 8 (44.4%)
Non obstetric complications 18 (8.2%) 8 (44.4%) 4 0-2 (0-11.1%) 8 (44.4%)
Coincidental 1 (0.5%) 1 (100%) 1 0 (0%) 0 (0%)
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Of the 220 women who received Level 2 Care, 
basic cardiovascular support (BCVS) was 
the most common (n=146, 66.7%, unknown 
for one case) organ support required (Table 
21). BCVS constituted invasive monitoring, 
primarily arterial line placement, and or IV 
anti-hypertensive. Of the 146 women who 
received BCVS, approximately 40% (n=61, 
41.8%) had received a magnesium sulphate 
infusion as a prophylaxis of eclampsia in 
severe pre-eclampsia.
Almost one in four women who received 
Level 2 Care required neurological support 
(n=50, 22.8%). Neurological support as the 
sole criterion for Level 2 Care included cases 
requiring magnesium sulphate infusion for 
the prophylaxis of eclampsia with no other 
organ support required (n=47 of 50 cases, 
94.0%). This is an area of discussion as the 
criteria refer to neurological support using 
magnesium sulpha te for prophylaxis against 
recurrent eclamptic seizures. As the decision 
to use magnesium is based on clinical 
concerns for a high risk for ensuing eclampsia, 
the work load and care is equivalent and 
therefore we have classified these cases as 
Level 2 Care.
Organ support required
Table 21: Single organ support required during Level 2 Care
Organ support required N (%)
Basic Cardiovascular Support (BCVS) 146 (66.7%)
Advanced Cardiovascular Support (ACVS) 1 (0.5%)
Basic Respiratory Support (BRS) 9 (4.1%)






*BRS and BCVS occurring simultaneously during the episode count as a single organ support
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Table 22: Highest level support location for women who required Level 2 Care in 15 Irish 
maternity units in 2014
Note: For women who were treated in more than one care setting during the clinical event, the setting offering the highest level of 
support is reported.
For women who required Level 2 Care only, 
the highest level support location during the 
clinical event is detailed in Table 22. Across 
the 15 participating units, just over half of 
these women were treated in an obstetric 
HDU and one third were treated in an ICU/
CCU. In maternity units with fewer than 2,500 
births per year, the majority of women (n=61, 
91%) requiring Level 2 Care were treated in an 
ICU/CCU. In maternity units with 2,500-6,000 
births per year, almost half (n=14, 45.2%) who 
required Level 2 Care were treated in an ICU/
CCU, whereas this was very rarely the case 
in a tertiary referral maternity hospital (n=2, 
1.6%). Variances across hospitals in location 
of care for women requiring Level 2 Care may 
reflect differences in resources available 
for obstetric Level 2 Care and a dependence 
on ICU/CCU facilities. HDU and ICU facilities 
available to maternity units in Ireland are 
illustrated on page 12 of this report.
Location during Level 2 Care
No of women 
who required 










All 15 reporting 
units 220 16(7.3%) 120(54.5%) 7(3.2%) 77(35.0%)
Maternity units with 








122 1(0.8%) 119(97.5%) - 2(1.6%)
Inter-hospital Transfer
Data on transfer details was available for 216 
of the 220 women requiring Level 2 Care. Of 
these 216 cases, 11 (5.1%) were transferred 
from another maternity unit and 1 (0.5%) case 
was transferred following a home birth delivery 
for Level 2 Care. Of the 11 cases transferred 
from another maternity unit, the majority (n=9, 
81.8%) of transfers were within the recipient 
unit’s HSE hospital network group.
A range of health care professionals attended 
during the 12 transfers for Level 2 Care and 
in some cases more than one healthcare 
professional was in attendance. Attending 
professionals included: midwife (n=6); 
obstetrician (n=4); nurse (n=4); anaesthetist 




National guidelines recommend the use of the 
Irish Maternity Early Warning System (IMEWS) 
to monitor all women who are clinically pregnant 
or who were delivered within the previous 42 
days . In the majority of cases (n=160, 74.1%; 
unknown for 4 cases), an IMEWS was used to 
monitor women prior to commencement of 
Level 2 Care. Of the 56 (25.9%) cases where 
an IMEWS was not used, it was reported that 
the woman was admitted either from home 
(n=7, 13%) or was cared for in a location which 
utilised a different monitoring tool (theatre, 
n=26, 48.1%; labour ward, n=17, 31.5%; 
emergency room/out-patient department, 
n=4, 7.4%; data missing for two cases).
Following commencement of Level 2 Care, 
an IMEWS was used in the management of 
over half (n=119, 54.6%) of the women.  In 
incidences when IMEWS was not used during 
Level 2 Care, a different monitoring tool was 
used in the majority (n=69, 69.7%) of cases.
Invasive monitoring
Data on the use of invasive monitoring was 
available for 216 of the 220 women receiving 
Level 2 Care. Of these 216 cases, over half 
(n=128, 59.3%) required invasive monitoring, 
most commonly the use of an arterial line. 
Table 23 outlines the incidence of invasive 
monitoring per category of maternal morbidity.
Table 23:  Invasive monitoring of women requiring Level 2 Care in 2014
Note: More than one invasive monitoring procedure was required in some cases therefore the percentages sum to more than 100%.
Maternal monitoring prior to and during Level 2 care







Hypertensive disorders 1 (4%) 40 (33.9) -
Obstetric Haemorrhage 13 (52%) 48 (40.7%) 1 (20%)
Pregnancy related infection 5 (20%) 15 (12.7%) 2 (40%)
Other obstetric 
complications 1 (4%) 2 (1.7%) 1 (20%)
Unanticipated complication 
of management - 1 (0.8%) -
Indirect 
Non obstetric complications 4 (16%) 12 (10.2%) 1 (20%)
Coincidental 1 (4%) - -
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22 Clinical Practice Guideline No 30 (2014). Guideline for the Critically ill Woman in Obstetrics : Institute of Obstetricians and 
Gynaecologists,  Royal  College  of  Physicians  of  Ireland  and  Directorate  of  Strategy  and  Clinical  Programmes,  Health  Service 
Executive
23 Providing equity of critical and maternity care for the critically ill pregnant or recently pregnant woman. Maternal Critical Care 
Working Group. Royal College of Obstetricians and Gynaecologists (2011)
Specialist review during Level 2 Care
Early consultation with anaesthetic staff 
is recommended in cases where there is 
a concern or a high risk of rapid maternal 
deterioration.22 Data on non-obstetric medical 
specialist review was available for 214 cases. 
Of these 214 cases, the majority (n=194, 
90.7%) of women were reviewed by a non-
obstetric medical specialist, most commonly 
(187, 87.4%) by an anaesthetist (Figure 8).
Early Pregnancy loss
Early pregnancy loss (pre-viable) was 
associated with a small number of cases (n=5, 
2.3%), of which most (n=4) were associated 
with pregnancy-related infection and a further 
case with major obstetric haemorrhage.
Neonatal outcome/care
Twelve of the 220 women who required Level 
2 Care experienced perinatal deaths, including 
one instance of twin perinatal deaths. There 
were nine stillbirths and four early neonatal 
deaths.
Location of neonatal care during maternal Level 
2 Care
It has been recommended that models of 
critical care should consider nursing mother 
and baby together unless precluded by a clinical 
indication.23 Of the 194 cases where a live born 
infant was delivered, the majority (147, 66.8%) of 
infants were not cared for at the same location as 
the mother during Level 2 Care. Of these, data on 
the location of care of the neonate was available 
for 145 cases. The majority (n=118, 81.4%) were 
admitted to the SCBU/NICU; 19 (13.1%) were 
cared for on a postnatal ward; and a further eight 
(5.5%) were cared for at the mother’s home, the 
mothers having been admitted in the postnatal 
period.Of the 118 infants admitted to SCBU/NICU, 
admission was required for the neonate’s own 
clinical condition in the majority (n=92; 78.0%) 
of cases. For the 26 (22.0%) infants who did not 
have a clinical indication for admission to the 
SBCU/NICU, the location of maternal care was in 
an ICU in all but one case.
Figure 8: Non obstetric medical specialist review during Level 2 Care
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Based on the WHO classification system for 
maternal deaths, over half (58.3%) of the women 
requiring Level 3 Care were classified as having 
a direct obstetric morbidity, nine (37.5%) were 
due to indirect causes and one case (4.2%) was 
attributed to a coincidental cause (Table 24). 
This is in contrast to national and international 
data on maternal mortality which has shown 
that the proportion of maternal deaths due to 
direct and indirect obstetric causes was 30% 
and 70% respectively.24,25
Table 24 demonstrates the number of maternal 
morbidities identified using the three different 
definitions for maternal morbidity: the NPEC 
SMM, the WHO NM and the WHO SMC criteria. 
In contrast to women requiring Level 2 Care 
only, the majority of maternal morbidity cases 
requiring Level 3 Care satisfied the criteria for 
the NPEC SMM (100%), the WHO NM (92.9%) 
and the WHO SMC (92.9%). For morbidities due 
to indirect and coincidental causes, the NPEC 
SMM and WHO NM definitions identified women 
in need of a higher level of care but only 22.2% 
of cases fulfilled the criteria for the WHO SMC.
Specific findings for women who required Level 3 Care
Maternal morbidity in women requiring Level 3 Care
24 O’Hare MF, Manning E, O’Herlihy C, Greene RA on behalf of MDE Ireland. Confidential Maternal Death
Enquiry in Ireland, Report for 2009 - 2012. Cork: MDE Ireland, February 2015.
25 Knight M, Tuffnell D, Kenyon S, Shakespeare J, Gray R, Kurinczuk JJ (Eds.) on behalf of MBRRACE-UK. Saving Lives, Improving 
Mothers’ Care - Surveillance of maternal deaths in the UK 2011-13 and lessons learned to inform maternity care from the UK and 
Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2009-13. Oxford: National Perinatal Epidemiology Unit, University 
of Oxford 2015. Available at: https://www.npeu.ox.ac.uk/mbrrace-uk






All (Direct, Indirect and 
Coincidental) 24 (100%) 24 (100%) 23 (95.8%) 15 (62.5%)
Direct 14 (58.3%) 14 (100%) 13 (92.9%) 13 (92.9%)
Pregnancy with abortive 
outcome - - - -
Hypertensive disorders 5 (20.8%) 5 (100%) 5 (100%) 5 (100%)
Obstetric Haemorrhage 7 (29.2%) 7 (100%) 7 (100%) 7 (100%)
Pregnancy related 
infection 1 (4.2%) 1 (100%) 1 (100%) 1 (100%)
Other obstetric 
complications 1 (4.2%) 1 (100%) 0 (0%) 0 (0%)
Indirect 9 (37.5%) 9 (100%) 9 (100%) 2 (22.2%)
Non obstetric 
complications 9 (37.5%) 9 (100%) 9 (100%) 2 (22.2%)
Coincidental 1 (4.2%) 1 (100%) 1 (100%) 0 (0%)
Table 24: Classification of maternal morbidity in women who required Level 3 Care in 2014 
according to the NPEC Severe Maternal Morbidity (SMM), WHO Near Miss (NM) and WHO severe 
maternal complication (SMC) criteria.
Note: Maternal morbidity definition criteria: NPEC SMM, the WHO Near Miss (NM) and the WHO Severe Maternal Complication 
(SMC) criteria. 1 This case fulfilled the criteria of the NPEC SMM audit due to ICU admission only
*Includes complications associated with early pregnancy loss.
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Advanced respiratory support was required 
for 15 of the 24 women requiring Level 3 Care 
(62.5%) and  neurological support was required 
for seven (29.2%) (Table 25).
Location of Level 3 Care 
For women requiring Level 3 Care, ICU was the 
location of care for the vast majority (n=18, 
75%) of cases with a further two women (8.3%) 
cared for in a CCU. Of the remaining four cases 
(16.7%), location of care was shared between a 
HDU and a renal unit for two women, and HDU 
and theatre for another two.
In the 20 cases where Level 3 Care was 
provided in an ICU or CCU, the ICU/CCU facility 
was on a co-located site for the majority of 
cases (n=18, 90%): and the remainder (n=2, 
10%) were cared for in an off-site location within 
the maternity unit’s HSE regional network. For 
the majority (n=18, 90.0%) of these 20 cases, 
there was no delay in accessing the ICU/CCU 
facility. In the two cases (10 %) where delayed 
access was reported, the estimated time delay 
was between 1 and 3.5 hours.
Communication and specialist review prior to 
Level 3 Care
Communication of critical information is an 
essential component of patient care, safety 
and risk management. A key recommendation 
in national guidelines is the necessity for a 
multidisciplinary care plan in the management 
of the critically ill pregnant woman.26
Information on whether a written 
multidisciplinary care plan accompanied 
the maternal transfer details to Level 3 Care 
was available for 19 (79%) of 24 cases. Of 
these, a written multidisciplinary care plan 
accompanied the maternal transfer details in 
the majority (n=14, 73.7%) of cases.
Of the 24 cases requiring Level 3 Care, it 
was reported that a discussion between the 
obstetric team and the anaesthetist or critical 
care intensivist occurred prior to admission 
for Level 3 Care in the majority (n=16, 66.6%; 
data missing for 8 cases) of cases. Almost all 
(n=22, 91.7%) women were reviewed by an 
anaesthetist or critical care intensivist prior to 
admission for Level 3 Care.
Interdisciplinary communication following 
Level 3 Care
Data on written interdisciplinary communication 
was available for 16 of the 24 Level 3 Care 
cases.  For all but one (93.8%) of the 16 cases, 
a written discharge summary of Level 3 Care 
was received by the referring obstetric team.
Organ support required
Table 25: Organ support required during Level 3 Care
Organ support required N (%)
Advanced Respiratory Support 15 (62.5%)
 Cardiovascular 6 (25.0 %)
Haematological 24 (33.3%)
Neurological 7 (29.2 %)
Renal 3 (12.5 %)
Note: More than one organ support is required in Level 3 Care therefore the percentages sum to more than 100%.
26 Clinical Practice Guideline No 30 (2014). Guideline for the Critically ill Woman in Obstetrics : Institute of Obstetricians and 
Gynaecologists,  Royal  College  of  Physicians  of  Ireland  and  Directorate  of  Strategy  and  Clinical  Programmes,  Health  Service 
Executive
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Maternal monitoring prior to and during Level 3 
Care 
For half (n=12, 50%) of the 24 women requiring 
Level 3 Care, an IMEWS was used to monitor the 
woman prior to commencement of Level 3 Care. 
Of the 12 (50 %) cases where an IMEWS was not 
used for maternal monitoring prior to Level 3 
Care, it was reported that the woman was cared 
for in a location using another physiological 
monitoring tool (theatre, n=6, 66.7 %; labour 
ward, n=1, 11.1%; HDU, n=1, 11.1%; and A&E, 
n=1, 11.1%; data missing for 3 cases).
The use of a specific physiological track and 
trigger tool for maternal monitoring during 
Level 3 Care was reported as unknown for 10 
(41.7%) cases. For the remaining 14 cases, a 
specific physiological track and trigger tool was 
used in almost all (n=13; 92.8%) cases.
Invasive monitoring
Almost all (n=23, 95.8%) women required 
invasive monitoring during Level 3 Care. An 
arterial line was used in all (n=23, 100 %) 
cases, over half (n=14, 60.9%) required a CVP 
and a further five (21.7 %) required another 
form of invasive monitoring.
Early Pregnancy loss
Early pregnancy loss (pre-viable) was 
experienced by one of the 24 women who 
required Level 3 Care.
Neonatal outcome/care
Three of the 24 women experienced perinatal 
death. These involved two stillbirths and one 
early neonatal death.
Location of neonatal care during maternal Level 
3 Care
Of the 19 cases where a live born infant was 
delivered, neonatal care was not provided at 
the same location as the mother during Level 3 
Care. Data on the location of care of the neonate 
was available for 18 cases: almost two thirds 
(n=13, 72.2 %) of neonates were admitted to 
the SCBU/NICU, two (11.1%) were nursed on 
a postnatal ward and a further three (16.7%) 
were cared for at the mother’s home. 
Of the 13 infants who were admitted to SCBU/
NICU, admission was required for the neonate’s 
own clinical condition in all (100%) cases. 
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Appendix B: National Office of Clinical Audit (NOCA) 
endorsement of the Severe Maternal Morbidity in 
Ireland Annual Report 2014 
 
National Office of Clinical Audit, 4th Floor, 121 St. Stephen’s Green, Dublin 2   Tel: 4028577                          
 
Professor Richard A. Greene 
Director 
National Perinatal Epidemiology Centre 
5th Floor, Cork University Maternity Hospital 
Wilton 
Cork 
          24th May 2016 
 
Severe Maternal Morbidity in Ireland, Annual Report 2014 
 
Dear Professor Greene, 
 
I acknowledge receipt of the Severe Maternal Morbidity Report 2014 and confirm following 
circulation to the NOCA Governance Board and feedback garnered from our membership, we are 
delighted to endorse this report.  
 
You and your NPEC colleagues are to be congratulated for the quality of the report and manner in 
which you continue to engage with maternity services to maintain this work.   
 
We note that the performance of maternity units in Ireland compare favourably when benchmarked 
against international comparators. 
 
We note your proposals for process improvement and welcome your recommendations which would 
enhance the learning from the audit and contribute to improvements in care for mothers and babies.  
This audit is an excellent example of why the Health Service should continue to invest in gathering 
data for quality improvement purposes.  We look forward to working with you and colleagues across 
other audit streams to ensure that audit is adequately resourced  
 






Professor Sean Tierney  
Chairman 
National Office of Clinical Audit 
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Appendix C: Hospital co-ordinators and  
contributors 2014
Hospital Co-ordinators Additional contributors
Cavan General Hospital Dr Rukhsana Majeed,  
Ms Karen Malocca
Coombe Women and Infants 
University Hospital
Dr Bridgette Byrne
Cork University  
Maternity Hospital 
Ms Katie Bourke,   
Ms Geraldine Hayes
 Prof Richard Greene
University Hospital  
Kerry
Ms Mary Stack Courtney, Ms Claire 
Fleming Kelliher
Letterkenny General  
Hospital
Ms Raphael Dalton, Ms Mary Doherty, 
Ms Geraldine Hanley, Ms Mary Lynch
Ms Evelyn Smith
Mayo General Hospital,  
Castlebar
Ms Diane Brady, Ms Pauline Corcoran Dr Hilary Ikele,  
Dr Meabh Ní Bhuinneain
Midland Regional Hospital, 
Mullingar
Ms Marie Corbett
Midland Regional Hospital, 
Portlaoise
Ms Ita Kinsella, Ms Emma Mullins Dr Miriam Doyle
National Maternity Hospital Dr  Azy Khalid
Our Lady of Lourdes Hospital, 
Drogheda
Ms Anne Keating Dr Seosamh Ó Cóigligh
Portiuncula Hospital, Ballinasloe Ms Mary Burke, Priscilla Neilan  
Rotunda Hospital, Dublin Dr Sharon Cooley
Sligo Regional Hospital Ms Juliana Henry Dr Heather Langan
South Tipperary General Hospital Ms Siobhan Kavanagh
St Luke’s Hospital, Kilkenny Ms Connie McDonagh
University Hospital Galway Ms Siobhan Canny Dr Geraldine Gaffney
University Hospital Waterford Ms Janet Murphy
Wexford General Hospital Ms Helen McLoughlin
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Appendix D: NPEC Governance Committee
Chair: *Dr Michael Robson, Consultant Obstetrician and Gynaecologist, National Maternity Hospital
Dr Michael Brassil, Consultant Obstetrician and Gynaecologist, Portiuncula Hospital
Professor Tom Clarke, Consultant Neonatologist, Rotunda Hospital
*Dr Sam Coulter-Smith, Master, Rotunda Hospital
Ms Marie Cregan, University College Cork - Patient Representative, nominated by HSE National Advocacy Unit
*Professor Declan Devane, Chair of Midwifery, National University of Ireland, Galway
*Dr Geraldine Gaffney, Senior Lecturer, National University of Ireland, Galway
Ms Ann Keating¸ Clinical Midwife Manager 3, Our Lady of Lourdes Hospital
Ms Geraldine Keohane, Director of Midwifery, Cork University Maternity Hospital
Dr Heather Langan, Consultant Obstetrician and Gynaecologist, Sligo General Hospital
Dr Rhona Mahony, Master, National Maternity Hospital
Ms Connie McDonagh, Clinical Midwife Manager 3, St. Luke’s General Hospital
*Dr Eleanor Molloy, Consultant Neonatologist, National Maternity Hospital
*Professor Deirdre Murphy, Chair in Obstetrics, Trinity Centre for Health Sciences, St. James Hospital
Dr Edward O’Donnell, Consultant Obstetrician and Gynaecologist, Waterford Regional Hospital
Dr Mary O’Mahony, Specialist in Public Health Medicine, HSE
Dr Sharon Sheehan, Master, Coombe Women and Infants University Hospital
*denotes membership of Data Access Sub-Group
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CONFIDENTIAL AUDIT  
OF 
SEVERE MATERNAL MORBIDITY IN IRELAND   
 
Notification Form:  2014  
 
Hospital Name _____________________________________________________ 
 
Completed by _____________________________________________________ 
(Please print name and staff grade)                            
  
Date of event:       
 
Time of onset of event:  (24 hour clock) 
 
 
Woman’s details  
 
Height at booking   ____________cm 
 
Weight at booking ____________kg 
* NPEC case number   
 
 
BMI    Parity:   + 
                                                                         
(Status prior to delivery) 
Date of delivery:   //Gestation at delivery/pregnancy end     
(or pregnancy end)                                                                                                   (Completed weeks)                                                                                                                                                                                                                                                                                                     
                                            
1. Ethnic group: 
White Irish             Irish Traveller 
Any other White background       Please specify country of origin   _____________________ 
Asian or Asian Irish                       Black or Black Irish 
 Other, including mixed ethnic backgrounds:                    Not recorded        
 
 




2.a. Did the woman smoke at booking?         Yes please specify quantity _____________ 
No       Not recorded 
2b. Did she give up smoking during pregnancy?  Yes     No       Not recorded N/A 
3. Did the woman drink alcohol at booking?          Yes    .No      Not recorded 
4. Is there documented history of drug abuse or attendance at a drug rehabilitation unit? 
None recorded       Prior to this pregnancy        During this pregnancy   
 
5 Obstetric history: Did the woman have a previous caesarean section      Yes       No 
6. This Pregnancy 
6 a. Was this pregnancy the result of infertility treatment? Yes    No       Unknown 
6 b. If yes please specify method of fertility treatment __________________________________ 
7. Was this an early pregnancy loss?   No Yes: MiscarriageYes: Ectopic pregnancy  
If early pregnancy loss please go to question 10 
 
8 Delivery Details 
8a. Onset of Labour:              Spontaneous          Induced          Never in labour 
8b. Lie of fetus at delivery        Longitudinal              Oblique                   Transverse  
8c. Presentation at delivery             Cephalic             Breech                             Other  
8d. Number of fetuses/babies in this delivery   
 
9. Mode of delivery: 
 Baby 1 Baby 2*  Baby 1 Baby 2* 
i) Spontaneous vaginal  
delivery       
vi) Elective LSCS not 
in labour      
 
              
ii) Assisted vaginal   
breech delivery       
vii) Elective LSCS in 
labour      
 
              
iii) Ventouse vaginal   
delivery       
viii) Emergency LSCS 
not in labour      
 
 
iv) Non-rotational forceps  
vaginal delivery       
ix) Emergency LSCS 
in labour      
 
 
v) Rotational forceps  
vaginal delivery       
x) Classical 
Caesarean Section      
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10. Neonatal Outcome 
Please answer yes or no as applicable  
Baby Outcomes Baby 1 Baby 2 Baby 3 
Birth weight in grams    
Intubation following delivery     
Transferred to SBCU/NICU    
*Early Neonatal Death     
*Late Neonatal Death      
Intrauterine death ≥ 500g and/or ≥ 24 weeks gestation    
*Please refer to reference manual for definitions 
 
11.Maternal Care Details 
11a. Location of Care during clinical event: 
Please tick all that apply 
On the ward                 Delivery Suite         High dependency unit            ICU/CCU  
11 b. Level of Care Required:  
 
Please indicate the highest level of care required during the clinical event: 
 
Level of care  Definition Please tick one box 
Level 0: Normal ward care  Care of low risk pregnant women   
 
Level 1: Additional monitoring or 
intervention, or step down from 
higher level of care 
Patients at risk of their condition 
deteriorating and needing a higher level 
of observation or those recently 
relocated from higher levels of care 
 
Level 2: Single Organ Support**  Patients requiring invasive monitoring/ 
intervention* including support for a 
single failing organ system (excluding 
advanced respiratory support). 
 
Level 3: Advanced respiratory 
support alone, or support of two 
or more organ systems** 
Patients requiring advanced respiratory 
support (mechanical ventilation) alone or 
basic respiratory support along with 
support of at least one additional organ. 
 
* invasive monitoring/intervention includes the use of arterial and CVP lines  




Level 2 examples 
Basic Respiratory Support (BRS): 50% or more oxygen via face-mask to maintain oxygen saturation; Continuous Positive Airway 
Pressure (CPAP), Bi-Level Positive Airway Pressure (BIPAP) 
Basic Cardiovascular Support (BCVS): Intravenous anti-hypertensive, to control blood pressure in pre-eclampsia; Arterial line used for 
pressure monitoring or sampling; CVP line used for fluid management and CVP monitoring to guide therapy 
Advanced Cardiovascular Support (ACVS): Simultaneous use of at least two intravenous, anti-arrhythmic/anti-hypertensive/vasoactive 
drugs, one of which must be a vasoactive drug; Need to measure and treat cardiac output 
Neurological Support: Magnesium infusion to control seizures / other  
Hepatic Support: Management of acute fulminant hepatic failure, e.g. from HELLP syndrome or acute fatty liver, such that 
transplantation is being considered 
 
Level 3 examples 
Advanced Respiratory Support: Invasive mechanical ventilation 
Support of two or more organ systems: Renal support and BRS; BRS/BCVS and an additional organ supported; Intracranial pressure 
monitoring 
Reference:  Saravanakumar K, Davies L, Lewis M, Cooper GM.. High dependency care in an obstetric setting in the UK. Anaesthesia 
2008:63, 1081–6. 
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Appendix F: The Robson Ten Group  
Classification System27
1 Nulliparous women with a single cephalic pregnancy, at greater than or equal to 37 weeks gestation in 
spontaneous labour
2 Nulliparous women with a single cephalic pregnancy, at greater than or equal to 37 weeks gestation who 
either had labour induced or were delivered by caesarean section before labour
3 Multiparous women, without a previous uterine scar, with a single cephalic pregnancy at greater than or 
equal 37 weeks in spontaneous labour
4 Multiparous women, without a previous uterine scar, with a single cephalic pregnancy at greater than or 
equal to 37 weeks gestation who either had labour induced or were delivered by caesarean section
5 All multiparous women, with at least one previous uterine scar and a single cephalic pregnancy at greater 
than or equal to 37 weeks gestation
6 All nulliparous women with a single breech pregnancy
7 All multiparous women with a single breech pregnancy including, women with previous uterine scars
8 All women with multiple pregnancies, including women with previous uterine scars
9 All women with a single pregnancy with a transverse or oblique lie, including women with previous 
uterine scars
10 All women with a single cephalic pregnancy at less than or equal to 36 weeks gestation, including women 
with previous scars
27 MS Robson (2001). Classification of caesarean sections. Fetal and Maternal Medicine Review, 12, pp 23-39 doi:10.1017/S0965539501000122
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Appendix G: National Guidelines for the critically ill 
woman in obstetrics28
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Appendix H: NPEC Critical Care Form 2014 – Detailed 






CONFIDENTIAL AUDIT of   
 
 







Detailed Case Assessment Form of Level 2 & Level 3 














Please return completed forms to: 
Edel Manning 
Project manager 
National Perinatal Epidemiology Centre 
Department of Obstetrics and Gynaecology 
5th Floor, Cork University Maternity Hospital 
Wilton 
Cork 
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Rationale for this confidential Audit 
 
As part of the on-going confidential clinical audit on severe maternal morbidity in Ireland, the National Perinatal 
Epidemiology Centre (NPEC) aims to conduct an audit on pregnant or recently pregnant women (this includes women 
in the postpartum period and women following early pregnancy loss) requiring Level 2 and Level 3 Critical Care. 
Please see Table1 on page 8 for definitions. 
 
Objectives of this audit are: 
 
 To identify the number of women requiring Level 2 and Level 3 Care in the Irish maternity services 
 To identify the location where critical care is provided  
 To identify resources and other issues impacting on access to and provision of Level 3 care  
 To evaluate the use of ICU/CCU facilities within the Irish Maternity Services. 
 
Please note obstetric patients who are admitted to ICU will be subject to the Intensive Care National Audit and 
Research Centre, (ICNARC) audit. The NPEC confidential audit on critical care in obstetrics compliments the ICNARC 
audit from an obstetric view point. There is no duplication of data collection.  
 
The NPEC is sincerely grateful for your contribution to this audit 
 
Inclusion criteria for the audit of Critical Care in Obstetrics: 
All pregnant or recently pregnant women (up to and including 42 days following delivery, miscarriage, termination of 
pregnancy or ectopic pregnancy) who require Level 2 or Level 3 Care. 
 
Guidelines for completing notification and case assessment forms  
 Definitions and examples of levels of care are outlined in Table1 on page 8 
 Abbreviations are outlined in Table 2 on page 8  
 Please mark the category box on the top of page 1 indicating Level of critical care provided/sequence of care 
 ‘Not known’ codes should be used as sparingly as possible 
 Please ensure that the NPEC Severe Maternal Morbidity Notification Form is completed (either online 
via the NPEC online database or in hard copy form) along with this form  




Thank you for taking the time to complete this form 
•Section 1 & 2 (questions 1- 17)
•Ensure Severe Maternal Morbidity 
Notification Form has been completed 
Women requiring 
Level 2 Care only
•Sections 1 & 3 (questions 1 - 6 and 18 - 33 )
•Ensure Severe Maternal Morbidity 
Notification Form has been completed 
Women requiring 
Level 3 Care only
•Sections 1 & 2 & 3 (questions 1 - 33 )
•Ensure Severe Maternal Morbidity 
Notification Form has been completed 
Women requiring 













(Please print name and staff grade) 
 
1. Category of the level of Critical Care required in this clinical event 
If applicable please indicate the sequence of critical care provided in this clinical event: 
Level 2 Care only  
Level 3 Care only  
Level 2 Care followed by Level 3 Care   
Level 3 Care followed by Level 2 Care   
Level 2 Care followed by Level 3 Care 
followed by Level 2 
 
 
2. Date of Clinical Event: // 
          Day Month       Year 
 
3. Time of Event:         :   (24 hour clock)   
 
 
4a. Maternal age: 4b. Parity: (Status prior to delivery)  +   
5. Did this woman have a medical/surgical or psychiatric disorder that pre-existed this pregnancy? 
Yes   No  
If yes, please specify disorder(s) ______________________________________________ __________ 
6. Was this pregnancy identified as ‘high risk’ during the antenatal period?  Yes    No  
 
Section 2: Level 2 Care 
7. Duration of Level 2 Care in days/ part days:                    Days 
                                                       (e.g.1.5 days) 
 
8. Location where Level 2 Care was provided in this clinical event (Please tick  all that apply): 
Ward  (Please specify type, maternity/gynaecology/general)___________________________ 
 
Delivery Suite  Theatre  Dedicated HDU /Maternity Hospital  
 
Dedicated HDU/ General Hospital  ICU   CCU  
 
Other, please specify _____________________________ 
  
NPEC Reference Number:  
 
_________________________ 
(As issued from the online 
database) 
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9. Location of maternal care prior to Level 2 Care  
Home  Ward (Please specify type: maternity/gynaecology/general)___________________ 
Delivery Suite  Theatre  Dedicated HDU/Maternity Hospital   
Dedicated HDU/General Hospital  ICU   CCU  
Other, please specify _____________________________ 
 
Inter-hospital Transfer 
10a. Was this woman transferred from another hospital for Level 2 Care?  
Yes   No  (If no, please go to question 11a)  
*Inter-hospital transfer only:  
10b. Was the referring hospital within your HSE regional hospital network? Yes   No  
10c. Please indicate below all heath care professionals in attendance during transfer (please specify grade):  
Anaesthetist ________________  Obstetrician  _____________________ 
Midwife ________________   Nurse ___________       Other, please specify ___________________ 
11a. Please identify the organ system that required support during Level 2 Care  
(Please refer to page 8 for examples of organ support required in Level 2 Care) 
__________________________________________________________________________________________ 
__________________________________________________________________________________________ 
11b. If a Magnesium Sulphate infusion was transfused, what was the primary indication for the transfusion: 
Maternal: treatment for eclamptic seizure Fetal neuroprotection only 
 
Maternal:  prophylaxis of eclampsia in severe pre-eclampsia 
 
12. Please specify the main clinical diagnosis during Level 2 Care in this clinical event: 
__________________________________________________________________________________________ 
__________________________________________________________________________________________ 
Maternal monitoring prior to commencement of Level 2 Care 
13a. Was an IMEWS chart used prior to commencement of Level 2 Care?  
Yes   No (please go to question 13d) 
13b. If yes, on average how often were physiological observations recorded?  
        (e.g. every 30 minutes)                        Every                 hours                     minutes 
13c. What was the highest IMEWS score recorded prior to commencement of Level 2 Care?  
_________________________________________________________________________________________ 





Maternal monitoring during Level 2 Care:  
14a. Was an IMEWS chart used during Level 2 Care? Yes   No  
 
14b. Was the patient monitored using another specific physiological track and trigger system/tool? 
Yes   No  (please go to question 14d)  
 
14c. Were patient specific triggers identified using this system/ tool? Yes   No  
 
14d. Was invasive monitoring used?  Yes  No  
(If yes, please tick  all that apply) 
CVP line   Arterial line   Other  please specify_______________   
 
Specialist review: 
15. Was the woman reviewed by a non-obstetric medical specialist?   Yes    No  
(If yes, please tick  all that apply)  
Anaesthetist  Critical Care Intensivist  Haematologist  General surgeon  
Physician ____________________ Neurosurgeon  Cardiologist   Psychiatrist   
(Please specify speciality) 
 
Neonatal Care: 
16a. Location of neonate during maternal Level 2 Care 
Not applicable/not delivered or early pregnancy loss   With mother  (go to question 17a) 
Not with mother  please specify location _______________________________  
16b If neonatal care was transferred to SBCU/NICU, was SBCU/NICU care required for the neonate’s own 
clinical condition? Yes   No  
 
Discharge from Level 2 Care 
 
17a Please indicate the level of care required at discharge from Level 2 Care: 
Level 0  Level 1  Level 3  
17b Please identify the discharge location of this women following Level 2 Care: 
Ward (Please specify type, maternity/gynaecology/general )____________________ 
Delivery Suite  Theatre  Dedicated HDU Maternity Hospital  
Dedicated HDU General Hospital  ICU   CCU  Maternal Death  
Other, please specify ______________________ 
Please use this space to enter any relevant issues regarding provision of Level 2 Care in this event 
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Section 3: Level 3 Care 
18. Duration of Level 3 care in days/part days (e.g. 1.5 days):                           Days         
19a. Please identify the location where Level 3 Care was provided 
 
ICU   CCU   Other, please specify ______________________ 
19b. Where was the ICU/CCU care facilitated?  
Co-located site Off maternity hospital site/ within the HSE regional network  
Off maternity hospital site/ not within the regional network but within the HSE* In another jurisdiction* 
 
*If applicable, please specify reason for transfer of care outside your unit’s HSE regional network 
_________________________________________________________________________________________ 
20. Was there a delay in accessing an ICU/CCU bed?   Yes  No  
 
If yes, what was the estimated time delay in hours?  
21. Location of care prior to commencement of Level 3 Care:  
Ward  (Please specify type, maternity/gynaecology/general)________________________ 
 
Delivery Suite  Theatre  Dedicated HDU Maternity Hospital  
 
Dedicated HDU General Hospital  ICU   CCU   
 
Other, please specify _____________________________ 
 
22. What was the highest level of care provided prior to commencement of Level 3 Care?  
23a. Was the woman reviewed by an Anaesthetist or Critical Care Intensivist prior to ICU/CCU admission? 
Yes (If yes, please go to question 24a)    No        Unknown  
23b. Was there a discussion between the Obstetric Team and the Anaesthetist or Critical Care Intensivist 
prior to admission? 
Yes   No   Unknown  
Maternal monitoring prior to commencement of Level 3 Care 
24a. Was an IMEWS chart used prior to commencement of Level 3 Care?  
 
Yes   No  (If no, please go to question 24d) 
24b. If yes, on average how often were physiological observations recorded?  
        (e.g. every 30 minutes)                        Every                   hours                       minutes 












Maternal monitoring during Level 3 Care 
25a. Was the patient monitored using a specific physiological track and trigger system/tool? 
Yes    No  Unknown 
Invasive monitoring: 
 
25b. Was invasive monitoring used during Level 3 Care?  Yes   No   Unknown  
(If yes, please tick  all that apply) 
CVP line   Arterial line   Other  please specify_______________   
 
Communication/ transfer details: 
26. Did a written multidisciplinary care plan accompany the maternal transfer details to location of Level 3 
Care? 
Yes   No   Unknown  
If yes, which of the following were identified in the care plan? 
(Please tick  all that apply) 
Consultant Obstetrician Consultant Anaesthetist ICU/CCU Intensivist   Senior Midwife 
Neonatologist     Other, please specify ___________________ 
27. Please indicate all healthcare professionals in attendance during transfer to location of Level 3 Care 
(Please specify grade) 
Anaesthetist ________________ Obstetrician  _____________________ 
Midwife __________________ Other ___________________ 
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30. Please indicate in the Table below any organ dysfunction identified and organ support required both at 
commencement of and during Level 3 Care (Please tick  all that apply) 
Organ Dysfunction/Support At 
commencement of 
Level 3 Care 
During 





Basic Respiratory support (Definition page 8)  
    
Advanced respiratory support (mechanical ventilation)       
Neurological Dysfunction/Support: 
Prolonged unconsciousness (lasting ≥ 12 hours)……. 
Coma (including metabolic coma)…………………… 
Stroke…………………………………………………… 
Uncontrollable fits/status epilepticus………………… 
Total paralysis………………………………………….. 
    
    
    
    
    




Use of continuous Cardiac Vasoactive Drugs……... 
Severe hypoperfusion (lactate ≥ 4 mmol/L or severe 
acidosis (PH <7.1)……………………………………… 
    
    
    
    
Renal Dysfunction/Support: 
Oligouria, non-responsive to fluids or diuretics 
    
Dialysis for Acute Renal Failure     
Severe acute azotemia (creatinine ≥ 300 µmol/ml or ≥ 
3.5 mg/dL) 
    
Coagulation/Haematological Dysfunction/Support: 
Disseminated Intravascular Coagulopathy (DIC) ….. 
Severe thrombocytopenia (< 50, 000 platelets/ml)..... 
Transfusion of blood or red cells (≥ 5 units)………… 
    
    
    
Hepatic Dysfunction: 
Jaundice in the presence of pre-eclampsia, eclampsia 
    
Severe Acute Hyperbilirubinemia (bilirubin > 100 µmol 
/L or > 6.0 mg/dL) 
    
Uterine Dysfunction: Uterine haemorrhage or 
infection leading to hysterectomy………………….. 
    
Sepsis or Severe Systemic infection     






Location of neonate during Level 3 Care 
31 a. Location of Neonatal Care: 
Not delivered or early pregnancy loss  (please go to question 32) With mother  (please go to question 32) 
 
Not with mother, please specify location _________________________(please go to 31b) 
 
31b. If neonatal care was transferred to SBCU/NICU, was SBCU/NICU care required for the neonate’s own 
clinical condition? Yes   No  
 
32. Discharge details from Level 3 Care 
 
Please indicate the level of care required at discharge from Level 3 Care?  
Level 0 Care  Level 1 Care   Level 2 Care  Maternal Death  
Where was the discharge destination of this women following Level 3 Care? 
Ward  (Please specify type, maternity/gynaecology/general)________________________ 
 
Delivery Suite  Dedicated HDU Maternity Hospital   Dedicated HDU General Hospital  
 
Maternal Death Other, please specify _____________________________ 
 
33a Was a written discharge summary of Level 3 Care received by the referring Obstetric Team/Unit? 
Yes   (Please answer 33b)  No   Unknown  
33b Please indicate all personnel notified of maternal outcome following Level 3 Care: 
Referring Consultant Obstetrician Consultant Neonatologist   Consultant Anaesthetist 
Critical Care Intensivist Physicianplease specify speciality____________________ 
Senior Midwife General Practitioner  Public Health Nurse  Consultant Psychiatrist 




Thank you for taking the time to complete this form 
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Definitions of Levels of Care 
Table 1: Definitions of Level of Care  
Level of care Definition 
Level 0: Normal ward care  Care of low risk pregnant women  
Level 1: Additional monitoring or intervention, 
or step down from higher level of care 
Patients at risk of their condition deteriorating and needing a 
higher level of observation or those recently relocated from 
higher levels of care 
Level 2: Single Organ Support** Patients requiring invasive monitoring */ intervention 
including support for a single failing organ system (excluding 
advanced respiratory support). 
Level 3: Advanced respiratory support alone, 
or support of two or more organ systems** 
Patients requiring advanced respiratory support (mechanical 
ventilation) alone or basic respiratory support along with 
support of at least one additional organ. 
* Invasive monitoring includes the use of arterial and CVP lines  
 
Examples of Critical Care, Level 2 and Level 3: 
 
Level 2 Care: 
Basic Respiratory Support (BRS): 50% or more oxygen via face-mask to maintain oxygen saturation; Continuous 
Positive Airway Pressure (CPAP), Bi-Level Positive Airway Pressure (BIPAP) 
Basic Cardiovascular Support (BCVS): Intravenous anti-hypertensive, to control blood pressure in pre-eclampsia; 
Arterial line used for pressure monitoring or sampling; CVP line used for fluid management and CVP monitoring to 
guide therapy 
Advanced Cardiovascular Support (ACVS): Simultaneous use of at least two intravenous, anti-arrhythmic/anti-
hypertensive/vasoactive drugs, one of which must be a vasoactive drug; Need to measure and treat cardiac output 
Neurological Support: Magnesium Sulphate infusion to control seizures / other 
Hepatic Support: Management of acute fulminant hepatic failure, e.g. from HELLP syndrome or acute fatty liver, such 
that transplantation is being considered 
 
Level 3 Care: 
Advanced Respiratory Support: Invasive mechanical ventilation 
Support of two or more organ systems:  Renal support and BRS; 
 BRS/BCVS and an additional organ supported (BRS and BCVS occurring simultaneously during the episode count as 
a single organ support);  
Intracranial pressure monitoring 
References: Saravanakumar K, Davies L, Lewis M, Cooper GM. High dependency care in an obstetric setting in the 
UK. Anaesthesia 2008:63, 1081-6 
 
Table 2: Abbreviations  
Abbreviation  Definition  
CCU Coronary Care Unit  
HDU  High Dependency Unit  
ICU  Intensive Care Unit  
I-MEWS Irish Maternity Early Warning System  
 
If you have questions or difficulties regarding any aspect of the form, please do not hesitate to contact 
Edel Manning at: e.manning@ucc.ie, telephone: (021) 4205042 
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Appendix I: Classification of maternal mortality 
WHO Application of ICD-10 
The WHO Application of ICD-10 to deaths during pregnancy, childbirth and the puerperium: ICD-MM29
Maternal Death Deaths of women while pregnant or within 42 days of the end of the 
pregnancy* from any cause related to or aggravated by the pregnancy or 
its management, but not from accidental or incidental causes
Direct Deaths resulting from obstetric complications of the pregnant state 
(pregnancy, labour and puerperium), from interventions, omissions, 
incorrect treatment or from a chain of events resulting from any of the 
above.
Indirect Deaths resulting from previous existing disease, or disease that 
developed during pregnancy and which was not the result of direct 
obstetric causes, but which was aggravated by the physiological effects 
of pregnancy.
Coincidental Deaths from unrelated causes which happen to occur in pregnancy or the 
puerperium.
*Includes giving birth, ectopic pregnancy, miscarriage or termination of pregnancy.
Direct causes Examples of potential causes of deaths
1. Pregnancies with abortive outcome Abortion, miscarriage, ectopic pregnancy and other conditions leading to 
maternal death and a pregnancy with abortive outcome
2. Hypertensive disorders Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth 
and the puerperium
3. Obstetric Haemorrhage Obstetric diseases or conditions directly associated with haemorrhage
4. Pregnancy related infection Pregnancy-related, infection-based diseases or conditions
5. Other obstetric complications All other direct obstetric conditions not included in groups to 1–4
6. Unanticipated complications of 
management
Severe adverse effects and other unanticipated complications of medical 
and surgical care during pregnancy, childbirth or the puerperium
Indirect causes Non-obstetric conditions
7. Non obstetric complications e.g. Cardiac disease, Neurological disease, Infection not as a direct result 
of pregnancy, Other indirect causes
8. Unknown / Undetermined Maternal death during pregnancy, childbirth and the puerperium where 
the underlying cause is unknown or was not determined
9. Coincidental causes Death during pregnancy, childbirth and the puerperium due to external 
causes
29 World Health Organisation The WHO Application of ICD-10 to deaths during pregnancy, childbirth and the puerperium: ICD-MM 2012 France.
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Appendix J: The WHO classification of severe  
maternal complications30
Severe maternal complication Definition
Severe postpartum haemorrhage Genital bleeding after delivery, with at least one of the following: 
perceived abnormal bleeding (≥ 1000 ml) or any bleeding with 
hypotension or blood transfusion.
Severe pre-eclampsia Persistent systolic blood pressure of 160 mmHg or more or a diastolic 
blood pressure of 110 mm Hg; proteinuria of 5 g or more in 24 hours, 
oliguria of < 400 ml in 24 hours; and HELLP syndrome or pulmonary 
oedema. Excludes eclampsia.
Eclampsia Generalised fits in a patient without a previous history of epilepsy. 
Includes coma in pre eclampsia.
Severe systemic infection or sepsis Presence of fever (body temperature > 38 degrees C), a confirmed 
or suspected infection (e.g. chorioamnionitis, septic abortion, 
endometritis, pneumonia), and at least one of the following: heart rate 
> 90, respiratory rate > 20, leukopenia (white blood cells < 4000), 
leucocytosis (white cells > 12 000).
Uterine rupture Rupture of uterus during labour confirmed by laparotomy. 
30 Evaluating the quality of care for severe pregnancy complications. The WHO near-miss approach for maternal health. World Health Organization; 2011
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Appendix K: The WHO organ-dysfunction criteria 
defined as Near Miss31
Morbidity Definition 
Cardiovascular dysfunction Shock, use of continuous vasoactive drugs, cardiac arrest, cardio-
pulmonary  resuscitation, severe hypoperfusion (lactate >5mmol/L or 
>45mg/dL) or  severe acidosis (pH<7.1)
Respiratory dysfunction Acute cyanosis, gasping, severe tachypnea (respiratory rate>40 bpm), 
severe  bradypnea (respiratory rate<6 bpm), severe hypoxemia (PAO2/
FiO2<200  O2 saturation <90% for ≥60min) or intubation and ventilation 
not related to anaesthesia
Renal dysfunction Oliguria non responsive to fluids or diuretics, dialysis for acute renal 
failure or severe acute azotemia (creatinine ≥300umol/ml or ≥3.5mg/
dL)
Coagulation/haematologic dysfunction Failure to form clots, massive transfusion of blood or red cells (≥ 5 units) 
or  severe acute thrombocytopenia (<50,000 platelets/ml)
Hepatic dysfunction Jaundice in the presence of pre-eclampsia, severe acute 
hyperbilirubinemia  (bilirubin>100umol/L or >6.0mg/dL)
Neurologic dysfunction Prolonged unconsciousness / coma (lasting >12 hours), stroke, status 
epilepticus / uncontrollable fits or  total paralysis
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